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DNA methylation is a modifiable epigenetic mechanism that regulates gene 
expression without changing the  nucleotide sequence (1).  As a basic biochemical 
process, DNA methylation directs tissue-specific transcription and suppresses expression 
of viral genes and transposable elements.  However, inappropriate gene expression or 
silencing can lead to disease - the most widely studied being cancer (2).  Genome-wide 
methylation content (‘global DNA methylation’) also plays a role in pathogenesis (3).  
Although there is prolific literature on the consequences of aberrant tissue-specific global 
DNA methylation in tumors (4-8), less is known regarding the value of systemic global 
DNA methylation measured from peripheral leukocytes as a biomarker of disease risk. 
Epidemiologic studies in adults indicate that alterations in peripheral leukocyte 
global DNA methylation are related to risk of obesity-related chronic diseases (9-12).  
Yet, the association of DNA methylation with body size remains unclear, and there is 
hardly any research in pediatric populations.  Considering that the childhood obesity 
epidemic represents one of the greatest current public health challenges, it is critical to 
elucidate biological mechanisms involved in excess weight gain for effective 
interventions.  Identifying modifiable predictors of global DNA methylation, such as diet, 
and understanding its relation with weight status would have important ramifications for 




This work aims to identify nutritional and sociodemographic correlates of global DNA 
methylation, and to investigate its relation with early life weight gain. 
Aim 1: To evaluate whether dietary intake of methyl-donor (folate) and methylation 
cofactor (vitamin B12, vitamin B6, zinc, and methionine) micronutrients is associated 
with two measures of global DNA methylation (LINE-1 and Alu repetitive elements), 
and to assess the relation of total plasma homocysteine with global DNA methylation in a 
cohort of healthy middle-aged adult participants in Multi-Ethnic Study of Atherosclerosis 
(MESA) Stress Study. 
Aim 2: To examine whether micronutrient biomarkers (erythrocyte folate; plasma vitamin 
B12, vitamin A, and ferritin; and serum zinc) are associated with global DNA 
methylation, quantified by methylation of LINE-1 repetitive elements, in a representative 
group of low- and middle-income school children from Bogotá, Colombia (the Bogotá 
School Children Cohort; BSCC).  A secondary endpoint is to assess the relations of 
maternal and child sociodemographic characteristics with LINE-1 methylation. 
Aim 3: To investigate the prospective association of global LINE-1 DNA methylation at 
time of recruitment into the BSCC with three indicators of adiposity (age- and sex-
standardized body mass index (BMI), an indicator of overall adiposity; age- and sex-
standardized abdominal circumference, a measure of central visceral adiposity;  and age- 
and sex- standardized subscapular-to-triceps skinfold thickness ratio, an index of 
subcutaneous truncal adiposity) and linear growth (height-for-age Z-score) during a 
median of 2.5 years of follow-up.   
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DNA methylation in health and disease 
Human epidemiologic and animal model data indicate that susceptibility to non-
communicable adult-onset diseases is influenced by the prenatal and early postnatal 
environment (13-16).  The underlying biological mechanisms were unclear until recent 
research in the field of epigenetics shed light on ways in which the epigenome and 
environment interact to induce lifelong phenotypic changes.  DNA methylation, the 
covalent addition of a methyl group to the fifth carbon of cytosine at cytosine-guanine 
dinucleotides (‘CpG sites’), is a stable and well-characterized epigenetic mechanism that 
plays a critical role in health and disease.  As a fundamental biochemical process of 
mammalian development, DNA methylation regulates gene expression by physically 
blocking transcriptional proteins from binding to a gene (17), or by influencing chromatin 
configuration through associations with methyl-CpG-binding domain proteins (MBDs) 
(18).  In addition to directing tissue-specific cell differentiation during embryogenesis, 
DNA methylation is involved in a number of other key processes including genomic 
imprinting (19), X-chromosome inactivation (20), oncogene silencing (21), and 
suppression of endogenous retroviruses (22).   
Because DNA methylation is a highly regulated process, there is little inter-
individual variability in methylation patterns across differentiated cells and tissues. 
Accordingly, sources of systemic between-person variation in DNA methylation, such as 
metastable epialleles (23) and transposable element insertion sites (14), provide a unique 
opportunity to link epigenetic dysregulation to disease.  The stochastic nature of de novo 
DNA methylation at these regions during embryogenesis makes the epigenome 
particularly vulnerable to environmental and metabolic factors (23, 24).  After cell 
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differentiation, DNA methylation patterns are preserved and maintained in the germ 
layer, resulting in marked inter-individual variation.  Animal models (25-27) and human 
studies (28-30) indicate that the methylation profile in these regions may reflect 
environmental influences in utero and throughout life, providing evidence that DNA 
methylation could serve as a mechanistic link between environmental factors and health 
outcomes. 
Inappropriate losses of (hypomethylation) or increases in (hypermethylation) 
gene-specific methylation are established causes of pathogenesis.  Global DNA 
methylation, estimated by methylation of repetitive and transposable elements such as 
long interspersed nucleotide element (LINE)-1 and Alu (31), has recently received 
attention as a measure of genomic stability (32) and a potential biomarker of disease risk.  
Transposable elements are endogenous and ubiquitous remnants of ancestral infections 
fixed in germ-line DNA that comprise approximately 45% of the human genome (33).  
LINE-1 and Alu have the ability to amplify and propagate to new genomic locations 
through a cut-and-paste mechanism, inducing chromosomal strand breaks and mutations 
(34).  Due to the deleterious consequences of their activity, transposable element sites are 
typically silenced through heavy methylation.  Loss of methylation in these regions 
contributes to genomic instability (4) and could be indicative of decreased genome-wide 
methylation content (32).  Studies have consistently demonstrated that global DNA 
hypomethylation of peripheral leukocytes is a risk factor for human cancers (35), and 
recent findings indicate that aberrant changes in leukocyte DNA methylation is related to 
risk of several other prominent chronic diseases (10, 11, 36), underscoring the value in 
understanding the role of this modifiable epigenetic mark in disease etiology. 
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Predictors of DNA methylation: The role of nutrition 
Although DNA methylation occurs mainly during intrauterine development, it is 
responsive to environmental modifications and can change sporadically throughout life 
(37).  Researchers found that peripheral leukocyte global DNA methylation decreased 
after exposure to environmental agents including black carbon traffic particles (38) and a 
low-dose of benzene (39).  Similarly, plasma concentrations of several persistent organic 
pollutants were inversely related to global DNA methylation in a study of Greenlandic 
Inuit (40).  Global DNA methylation is also associated with various epidemiologic risk 
factors such as age (41), sex (42, 43), race/ethnicity (42, 43), dietary patterns (44), body 
size (10, 11), physical activity (45), and alcohol and tobacco use (42).  While the 
mechanisms that underlie these associations remain unclear, dietary intake of certain 
micronutrients, including methyl-donors and retinoids, play a direct role in DNA 
methylation pathways. 
One-carbon metabolism is a cyclical physiological process that ultimately 
provides the methyl group in all mammalian DNA methylation reactions. The transfer of 
the methyl group from the universal methyl-donor, S-adenosylmethionine (SAM), to the 
5th carbon of the cytosine ring is catalyzed by the DNA methyltransferases (DNMTs) in 
the presence of methyl-donor micronutrients such as folate and choline, and methylation 
cofactors including vitamin B12, vitamin B6, vitamin B2, and zinc (see Figure 1.1 for 
details of DNA methylation pathways).  The folate-mediated and choline-mediated 
methylation pathways intersect at the formation of methionine, the precursor of SAM, 
from homocysteine. Successful recycling of methionine from homocysteine is essential to 
the procurement of SAM for subsequent methylation reactions.  Because methyl-donors 
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and methylation cofactors are obtained from the diet, an imbalance or deficiency can lead 
to elevated plasma homocysteine (46, 47), which is a cause of oxidative stress and an 
established marker of cardiovascular disease risk (48).  Additionally, high homocysteine 















Figure 1.1 Involvement of dietary micronutrients in one-carbon metabolism. Substrates obtained from dietary 
sources are shaded in gray. Folic acid enters one-carbon metabolism as tetrahydrofolate (THF).  The conversion of 
THF to 5,10-methylene THF is catalyzed by cofactor vitamin B6 and serine hydroxy-methyltransferase. Vitamin B2, 
precursor to flavin adenine dinucleotide (FAD), is a cofactor to methylenetetrahydrofolate reductase (MTHFR) in the 
conversion of 5,10-methylene THF to 5-methyl THF.  Vitamin B12 is a precursor to methionine synthase, which is 
involved in the production of methionine and dimethylglycine (DMG) from homocysteine and betaine.  Zinc is a 
cofactor to the DNA methyltransferases (DNMT) in the transfer of the methyl group from S-adenosylmethionine 
(SAM) to the the 5th carbon of cytosine.  Demethylated SAM becomes S-adenosylhomocysteine (SAH), which is 
subsequently hydrolyzed to homocysteine by adenosylhomocysteinase. Homocysteine can be recycled back to 
methionine with adequate methyl-donor (folate and choline) and methylation cofactor (vitamin B12, vitamin B6, 
vitamin B2, and zinc) micronutrients. Figure and text adapted from Anderson et al 2012 (51). 
 
However, the literature regarding the relation of micronutrient status with global DNA 
methylation is inconsistent.  Some controlled-feeding trials in adults have found changes 
in global DNA methylation following folate supplementation and depletion (52, 53), 
while others showed no effect (54-57).  Findings from cross-sectional studies are also 
discordant.  Intake of methyl-donor micronutrients was not related to global DNA 
methylation in one study of healthy middle-aged adults (44), while another study reported 
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a positive correlation between folate intake from fortified foods and global DNA 
methylation (58).  Two perinatal studies conducted to examine the relations of maternal 
nutrient intake with DNA methylation during early life (59, 60) reported no relation 
between micronutrient status and cord blood DNA methylation.  The discrepancies in 
study findings could be due to differences in study design, potential recall bias of dietary 
intake in observational studies, and variability in study population characteristics.  There 
is also considerable variation in the methodology used to determine global DNA 
methylation, ranging from the [(3)H]-methyl group acceptance assay, which is inherently 
limited by its in vitro stability (61), to various pyrosequencing-based assays.  
In addition to the micronutrients involved in one-carbon metabolism, retinoids 
can also influence DNA methylation by affecting DNMT activity.  For example, 
treatment of breast cancer cells with all trans retinoic acid (atRA), the most biologically 
active metabolite of vitamin A, inhibited cell growth by reducing DNMT expression in a 
highly differentiated cancer cell line (62).  A reduction in DNMT activity could lead to 
decreased DNA methylation since the DNMTs catalyze the methylation reaction.  
Unfortunately, the DNMT-inhibitory effects of retinoic acid treatments have only been 
examined in the context of chemoprevention and cancer therapies, and little is known 
regarding its influence on global DNA methylation. 
The limited and discordant findings point toward the need to improve 
understanding of how dietary factors influence global DNA methylation in healthy 
populations.  Additionally, use of reliable and reproducible laboratory techniques to 




Global DNA methylation and obesity 
Animal models provide evidence that changes in DNA methylation patterns can 
influence risk of obesity and obesity-related diseases (25, 26, 63).  In the yellow Agouti 
mouse, the protective effect of methyl-donor micronutrient intake against obesity was 
specifically due to increased methylation of the Avy metastable epiallele (25, 26).  In 
humans, researchers have identified alterations in gene-specific methylation that were 
related to weight change (64, 65) and weight status (66, 67) in obese patients.  While 
gene-specific changes provide insight into regulatory pathways, changes at the global 
level are also important to consider because global DNA methylation is responsive to 
environmental modifications (38), and because genomic stability has health implications 
beyond the function of a specific gene.   
Despite findings that global DNA methylation is related to several obesity-related 
diseases including cardiovascular disease (9-11), metabolic syndrome (68), and diabetes 
(12), little is known regarding the direct relation between global DNA methylation and 
body size.  Current knowledge consists mostly of mixed findings from cross-sectional 
studies in adult populations (10, 11, 42, 43).  Some studies from maternal-infant dyads 
have been conducted to investigate relations of perinatal characteristics, including birth 
weight, with cord blood DNA methylation (59, 60, 69).  One study reported that high and 
low birth weight, as well as premature birth were associated with significantly lower cord 
blood DNA methylation (69).  However, inference from perinatal studies is limited, as it 
is not known whether functional consequences of these associations contribute to obesity 
in later life.  To date, the largest gap in literature is the lack of longitudinal studies to 
assess the temporal relation between global DNA methylation and subsequent changes in 
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anthropometry.  While cross-sectional studies provide a preliminary idea of how global 
DNA methylation and body size are related, they cannot overcome the potential for 
reverse causation bias.  Furthermore, little is known regarding global DNA methylation 
and weight status in children.  Pediatric populations are an ideal setting to examine this 
relation, as the childhood epigenome has endured fewer environmental exposures that 
could obscure the associations of interest.  Furthermore, animal models indicate that 
DNA methylation profiles are sensitive to external stimuli, such as dietary intake, during 
specific postnatal periods, and that the epigenetic changes can influence body 
composition (27).  Because adipocyte quantity is not set until early adolescence (70), the 
childhood years represent a particularly important time frame to elucidate molecular 
mechanisms involved in adipogenesis for obesity intervention efforts.  Considering the 
compelling evidence that excess weight gain in early life is related to increased 
cardiometabolic morbidity in adulthood (71, 72), it is critical to understand biological 




Summary of Chapters 
This dissertation expands the existing knowledge surrounding predictors of global 
DNA methylation by elucidating its association with modifiable nutritional and 
sociodemographic characteristics in adults and children. This work also addresses the 
chasm in epigenetic pediatric research, and the need for longitudinal studies to clarify the 
temporal relation of global DNA methylation with excess weight gain.  The associations 
examined are depicted in the conceptual framework shown in Figure 1.2.   
The first two analytic chapters are focused on micronutrients and global DNA 
methylation, quantified using a highly reproducible pyrosequencing technique (31). 
Chapter 2 uses data from the Multi-Ethnic Study of Atherosclerosis (MESA) Stress Study 
to assess the relations of methyl-donor/methylation cofactor micronutrient intake and 
total plasma homocysteine with two measures of global DNA methylation in an 
ethnically diverse population of healthy middle-aged adults.  Chapter 3 examines 
associations of micronutrient biomarkers and sociodemographic characteristics with 
global DNA methylation in a representative sample of low- and middle-income school-
age children from the Bogotá School Children Cohort (BSCC).  In Chapter 4, we used 
prospectively collected data to investigate the relation of global DNA methylation at time 
of recruitment into the BSCC with changes in adiposity and linear growth during a 
median of 2.5 years of follow-up.  Finally, a summary of the dissertation’s main findings, 




















Figure 1.2 Conceptual framework of how dietary intake, nutritional status, global DNA methylation 
and weight status are related. Shaded gray boxes are the main exposures and outcomes examined in the 





1. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome 
integrates intrinsic and environmental signals. Nat Genet 2003;33 Suppl:245-54. 
 
2. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 
2002;21(35):5400-13. 
 
3. Beck CR, Garcia-Perez JL, Badge RM, Moran JV. LINE-1 Elements in Structural 
Variation and Disease. Annu Rev Genomics Hum Genet 2011;12:187-215. 
 
4. Daskalos A, Nikolaidis G, Xinarianos G, Savvari P, Cassidy A, Zakopoulou R, et al. 
Hypomethylation of retrotransposable elements correlates with genomic instability in 
non-small cell lung cancer. Int J Cancer 2009;124(1):81-7. 
 
5. Suter CM, Martin DI, Ward RL. Hypomethylation of L1 retrotransposons in 
colorectal cancer and adjacent normal tissue. Int J Colorectal Dis 2004;19(2):95-101. 
 
6. Cho NY, Kim BH, Choi M, Yoo EJ, Moon KC, Cho YM, et al. Hypermethylation of 
CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate 
adenocarcinoma and their relationship to clinicopathological features. J Pathol 
2007;211(3):269-77. 
 
7. Menendez L, Benigno BB, McDonald JF. L1 and HERV-W retrotransposons are 
hypomethylated in human ovarian carcinomas. Mol Cancer 2004;3:12. 
 
8. Takai D, Yagi Y, Habib N, Sugimura T, Ushijima T. Hypomethylation of LINE1 
retrotransposon in human hepatocellular carcinomas, but not in surrounding liver 
cirrhosis. Jpn J Clin Oncol 2000;30(7):306-9. 
 
9. Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, Tarantini L, et al. 
Ischemic heart disease and stroke in relation to blood DNA methylation. 
Epidemiology 2010;21(6):819-28. 
 
10. Kim M, Long TI, Arakawa K, Wang R, Yu MC, Laird PW. DNA methylation as a 
biomarker for cardiovascular disease risk. PLoS One 2010;5(3):e9692. 
 
11. Cash HL, McGarvey ST, Houseman EA, Marsit CJ, Hawley NL, Lambert-Messerlian 
GM, et al. Cardiovascular disease risk factors and DNA methylation at the LINE-1 
repeat region in peripheral blood from Samoan Islanders. Epigenetics 2011;6(10). 
 
12. Zhao J, Goldberg J, Bremner JD, Vaccarino V. Global DNA Methylation Is 
Associated With Insulin Resistance: A Monozygotic Twin Study. Diabetes 2011. 
 
13. Waterland RA, Garza C. Early postnatal nutrition determines adult pancreatic 





14. Waterland RA, Jirtle RL. Early nutrition, epigenetic changes at transposons and 
imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition 
2004;20(1):63-8. 
 
15. Painter RC, de Rooij SR, Bossuyt PM, Simmers TA, Osmond C, Barker DJ, et al. 
Early onset of coronary artery disease after prenatal exposure to the Dutch famine. 
Am J Clin Nutr 2006;84(2):322-7; quiz 466-7. 
 
16. Painter RC, Roseboom TJ, Bleker OP. Prenatal exposure to the Dutch famine and 
disease in later life: an overview. Reprod Toxicol 2005;20(3):345-52. 
 
17. Siegfried Z, Eden S, Mendelsohn M, Feng X, Tsuberi BZ, Cedar H. DNA 
methylation represses transcription in vivo. Nat Genet 1999;22(2):203-6. 
 
18. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, et al. 
Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a 
histone deacetylase complex. Nature 1998;393(6683):386-9. 
 
19. Reik W, Walter J. Genomic imprinting: parental influence on the genome. Nat Rev 
Genet 2001;2(1):21-32. 
 
20. Chow JC, Yen Z, Ziesche SM, Brown CJ. Silencing of the mammalian X 
chromosome. Annu Rev Genomics Hum Genet 2005;6:69-92. 
 
21. Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev 
Genet 2002;3(6):415-28. 
 
22. Yoder JA, Walsh CP, Bestor TH. Cytosine methylation and the ecology of 
intragenomic parasites. Trends Genet 1997;13(8):335-40. 
 
23. Rakyan VK, Blewitt ME, Druker R, Preis JI, Whitelaw E. Metastable epialleles in 
mammals. Trends Genet 2002;18(7):348-51. 
 
24. Dolinoy DC, Das R, Weidman JR, Jirtle RL. Metastable epialleles, imprinting, and 
the fetal origins of adult diseases. Pediatr Res 2007;61(5 Pt 2):30R-7R. 
 
25. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects 
on epigenetic gene regulation. Mol Cell Biol 2003;23(15):5293-300. 
 
26. Dolinoy DC, Huang D, Jirtle RL. Maternal nutrient supplementation counteracts 
bisphenol A-induced DNA hypomethylation in early development 
Proc Natl Acad Sci U S A 2007;104(32):13056-61. 
 
27. Burdge GC, Lillycrop KA, Phillips ES, Slater-Jefferies JL, Jackson AA, Hanson MA. 
Folic acid supplementation during the juvenile-pubertal period in rats modifies the 
14 
 
phenotype and epigenotype induced by prenatal nutrition. J Nutr 2009;139(6):1054-
60. 
 
28. Fraga MF, Ballestar E, Paz MF, Ropero S, Setien F, Ballestar ML, et al. Epigenetic 
differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci U S A 
2005;102(30):10604-9. 
 
29. Waterland RA, Kellermayer R, Laritsky E, Rayco-Solon P, Harris RA, Travisano M, 
et al. Season of conception in rural gambia affects DNA methylation at putative 
human metastable epialleles. PLoS Genet 2010;6(12):e1001252. 
 
30. Heijmans BT, Tobi EW, Lumey LH, Slagboom PE. The epigenome: archive of the 
prenatal environment. Epigenetics 2009;4(8):526-31. 
 
31. Yang AS, Estecio MR, Doshi K, Kondo Y, Tajara EH, Issa JP. A simple method for 
estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. 
Nucleic Acids Res 2004;32(3):e38. 
 
32. Weisenberger DJ, Campan M, Long TI, Kim M, Woods C, Fiala E, et al. Analysis of 
repetitive element DNA methylation by MethyLight. Nucleic Acids Res 
2005;33(21):6823-36. 
 
33. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, et al. Initial 
sequencing and analysis of the human genome. Nature 2001;409(6822):860-921. 
 
34. Callinan P, Batzer M. Retrotransposable elements and human disease. Genome Dyn 
2006;1:104-15. 
 
35. Woo HD, Kim J. Global DNA hypomethylation in peripheral blood leukocytes as a 
biomarker for cancer risk: a meta-analysis. PLoS One 2012;7(4):e34615. 
 
36. Baccarelli A, Tarantini L, Wright RO, Bollati V, Litonjua AA, Zanobetti A, et al. 
Repetitive element DNA methylation and circulating endothelial and inflammation 
markers in the VA normative aging study. Epigenetics 2010;5(3). 
 
37. Bjornsson HT, Sigurdsson MI, Fallin MD, Irizarry RA, Aspelund T, Cui H, et al. 
Intra-individual change over time in DNA methylation with familial clustering. 
JAMA 2008;299(24):2877-83. 
 
38. Baccarelli A, Wright RO, Bollati V, Tarantini L, Litonjua AA, Suh HH, et al. Rapid 
DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care 
Med 2009;179(7):572-8. 
 
39. Bollati V, Baccarelli A, Hou L, Bonzini M, Fustinoni S, Cavallo D, et al. Changes in 





40. Rusiecki JA, Baccarelli A, Bollati V, Tarantini L, Moore LE, Bonefeld-Jorgensen 
EC. Global DNA hypomethylation is associated with high serum-persistent organic 
pollutants in Greenlandic Inuit. Environ Health Perspect 2008;116(11):1547-52. 
 
41. Bollati V, Schwartz J, Wright R, Litonjua A, Tarantini L, Suh H, et al. Decline in 
genomic DNA methylation through aging in a cohort of elderly subjects. Mech 
Ageing Dev 2009;130(4):234-9. 
 
42. Zhu ZZ, Hou L, Bollati V, Tarantini L, Marinelli B, Cantone L, et al. Predictors of 
global methylation levels in blood DNA of healthy subjects: a combined analysis. Int 
J Epidemiol 2010. 
 
43. Zhang FF, Cardarelli R, Carroll J, Fulda KG, Kaur M, Gonzalez K, et al. Significant 
differences in global genomic DNA methylation by gender and race/ethnicity in 
peripheral blood. Epigenetics 2011;6(5):623-9. 
 
44. Zhang FF, Morabia A, Carroll J, Gonzalez K, Fulda K, Kaur M, et al. Dietary patterns 
are associated with levels of global genomic DNA methylation in a cancer-free 
population. J Nutr 2011;141(6):1165-71. 
 
45. Zhang FF, Cardarelli R, Carroll J, Zhang S, Fulda KG, Gonzalez K, et al. Physical 
activity and global genomic DNA methylation in a cancer-free population. 
Epigenetics 2011;6(3):293-9. 
 
46. Johnson MA, Hawthorne NA, Brackett WR, Fischer JG, Gunter EW, Allen RH, et al. 
Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using Title IIIc 
nutrition services. Am J Clin Nutr 2003;77(1):211-20. 
 
47. Lee JE, Jacques PF, Dougherty L, Selhub J, Giovannucci E, Zeisel SH, et al. Are 
dietary choline and betaine intakes determinants of total homocysteine concentration? 
Am J Clin Nutr 2010;91(5):1303-10. 
 
48. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham 
cohorts. J Nutr 2006;136(6 Suppl):1726S-30S. 
 
49. Cucu NV. DNA Methylation. In: Haggerty MDNP, editor. Nutrition in Epigenetics. 1 
ed. Oxford: Blackwell Publishing Ltd.; 2011. 
 
50. James SJ, Melnyk S, Pogribna M, Pogribny IP, Caudill MA. Elevation in S-
adenosylhomocysteine and DNA hypomethylation: potential epigenetic mechanism 
for homocysteine-related pathology. J Nutr 2002;132(8 Suppl):2361S-6S. 
 
51. Anderson OS, Sant KE, Dolinoy DC. Nutrition and epigenetics: an interplay of 





52. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, et al. Moderate 
folate depletion increases plasma homocysteine and decreases lymphocyte DNA 
methylation in postmenopausal women. J Nutr 1998;128(7):1204-12. 
 
53. Rampersaud GC, Kauwell GP, Hutson AD, Cerda JJ, Bailey LB. Genomic DNA 
methylation decreases in response to moderate folate depletion in elderly women. Am 
J Clin Nutr 2000;72(4):998-1003. 
 
54. Figueiredo JC, Grau MV, Wallace K, Levine AJ, Shen L, Hamdan R, et al. Global 
DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and 
dietary and genetic factors. Cancer Epidemiol Biomarkers Prev 2009;18(4):1041-9. 
 
55. Axume J, Smith SS, Pogribny IP, Moriarty DJ, Caudill MA. Global leukocyte DNA 
methylation is similar in African American and Caucasian women under conditions 
of controlled folate intake. Epigenetics 2007;2(1):66-8. 
 
56. Crider KS, Quinlivan EP, Berry RJ, Hao L, Li Z, Maneval D, et al. Genomic DNA 
Methylation Changes in Response to Folic Acid Supplementation in a Population-
Based Intervention Study among Women of Reproductive Age. PLoS One 
2011;6(12):e28144. 
 
57. Jung AY, Smulders Y, Verhoef P, Kok FJ, Blom H, Kok RM, et al. No effect of folic 
acid supplementation on global DNA methylation in men and women with 
moderately elevated homocysteine. PLoS One 2011;6(9):e24976. 
 
58. Zhang FF, Santella RM, Wolff M, Kappil MA, B. S. White blood cell global 
methylation and IL-6 promoter methylation in association with diet and lifestyle risk 
factors in a cancer-free population. Epigenetics 2012;7(6). 
 
59. Boeke CE, Baccarelli A, Kleinman KP, Burris HH, Litonjua AA, Rifas-Shiman SL, et 
al. Gestational intake of methyl donors and global LINE-1 DNA methylation in 
maternal and cord blood: prospective results from a folate-replete population. 
Epigenetics 2012;7(3):253-60. 
 
60. Fryer AA, Nafee TM, Ismail KM, Carroll WD, Emes RD, Farrell WE. LINE-1 DNA 
methylation is inversely correlated with cord plasma homocysteine in man: a 
preliminary study. Epigenetics 2009;4(6):394-8. 
 
61. Dahl C, Guldberg P. DNA methylation analysis techniques. Biogerontology 
2003;4(4):233-50. 
 
62. Hansen NJ, Wylie RC, Phipps SM, Love WK, Andrews LG, Tollefsbol TO. The low-
toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and 





63. Seki Y, Williams L, Vuguin PM, Charron MJ. Minireview: Epigenetic programming 
of diabetes and obesity: animal models. Endocrinology 2012;153(3):1031-8. 
 
64. Bouchard L, Rabasa-Lhoret R, Faraj M, Lavoie ME, Mill J, Perusse L, et al. 
Differential epigenomic and transcriptomic responses in subcutaneous adipose tissue 
between low and high responders to caloric restriction. Am J Clin Nutr 
2010;91(2):309-20. 
 
65. Milagro FI, Campion J, Cordero P, Goyenechea E, Gomez-Uriz AM, Abete I, et al. A 
dual epigenomic approach for the search of obesity biomarkers: DNA methylation in 
relation to diet-induced weight loss. FASEB J 2011;25(4):1378-89. 
 
66. Wang X, Zhu H, Snieder H, Su S, Munn D, Harshfield G, et al. Obesity related 
methylation changes in DNA of peripheral blood leukocytes. BMC Med 2010;8:87. 
 
67. Feinberg AP, Irizarry RA, Fradin D, Aryee MJ, Murakami P, Aspelund T, et al. 
Personalized epigenomic signatures that are stable over time and covary with body 
mass index. Sci Transl Med 2010;2(49):49ra67. 
 
68. Luttmer R, Spijkerman A, Kok R, Jakobs C, Blom H, Serne E, et al. Metabolic 
syndrome components are associated with DNA hypomethylation. Obes Res Clin 
Pract 2012;In Press. 
 
69. Michels KB, Harris HR, Barault L. Birthweight, Maternal Weight Trajectories and 
Methylation of LINE-1 Repetitive Elements. PLoS One 2011;6(9):e25254. 
 
70. Spalding KL, Arner E, Westermark PO, Bernard S, Buchholz BA, Bergmann O, et al. 
Dynamics of fat cell turnover in humans. Nature 2008;453(7196):783-7. 
 
71. Juonala M, Juhola J, Magnussen CG, Wurtz P, Viikari JS, Thomson R, et al. 
Childhood environmental and genetic predictors of adulthood obesity: the 
cardiovascular risk in young Finns study. J Clin Endocrinol Metab 
2011;96(9):E1542-9. 
 
72. Schmidt MD, Dwyer T, Magnussen CG, Venn AJ. Predictive associations between 
alternative measures of childhood adiposity and adult cardio-metabolic health. Int J 










Dietary intake, plasma homocysteine, and global DNA methylation in the  
Multi-Ethnic Study of Atherosclerosis (MESA) 
Wei Perng, Eduardo Villamor, Monal R. Shroff, Jennifer A. Nettleton,  
J. Richard Pilsner, Yongmei Liu, and Ana V. Diez-Roux 
 
Introduction 
Epigenetic mechanisms, such as DNA methylation, are heritable changes in gene 
expression made over the nucleotide sequence.  Genome-wide methylation content, or 
global DNA methylation, is a measure of genomic stability that is related to risk of adult 
onset diseases such as cancer (1).  Recent findings from epidemiologic studies indicate 
that aberrations in global DNA methylation could serve as a biomarker of cardiovascular 
disease (CVD) risk (2, 3).  Global DNA hypomethylation may play a role in CVD 
etiology through its relation with hyperhomocysteniemia (4), a prominent risk factor for 
endothelial injury and vascular disorders.  Considering that CVD is the leading cause of 
death in most countries (6), it is crucial to identify correlates of modifiable risk factors 
such as DNA methylation for effective interventions. 
Nutrition plays a key role in DNA methylation pathways. One-carbon metabolism 
is an essential process that provides the methyl group in all mammalian DNA 
methylation reactions. The reaction is catalyzed by several endogenous enzymes in the 
presence of methyl-donor micronutrients such as folate and choline, and methylation 
19 
 
cofactors including vitamin B12, vitamin B6, and zinc.  The folate- and choline-
dependent methylation pathways intersect at the formation of methionine, precursor to 
the universal methyl-donor S-adenosylmethionine (SAM), from homocysteine.  
Successful metabolic cycling of methionine from homocysteine ensures provision of 
SAM for subsequent methylation reactions. Because methyl-donor and methylation 
cofactor micronutrients are obtained from the diet, an imbalance or deficiency in these 
micronutrients can result in elevated plasma homocysteine concentrations, which is a 
marker of CVD risk (7). 
Although it is well-established that a deficiency in methyl-donor micronutrients 
can lead to hyperhomocysteinemia (8, 9), the relations of methyl-donor micronutrient 
intake and plasma homocysteine concentrations with global DNA methylation remain 
unclear.  Some controlled-feeding trials in adults have found changes in global DNA 
methylation following folate supplementation and depletion (10, 11), while others 
showed no effect (12-15).  Findings from cross-sectional studies have also been 
inconsistent.  Intake of methyl-donor micronutrients was not related to global DNA 
methylation among healthy adults in Texas (16), while another study of cancer-free 
adults in New York reported a positive correlation between folate intake from fortified 
foods and global DNA methylation (17).  In a recent study of Colombian schoolchildren, 
neither erythrocyte folate nor serum vitamin B12 concentrations were associated with 
global DNA methylation (18). Two perinatal studies have also been conducted to 
examine the relations of maternal nutrient intake with DNA methylation during early life 
(19, 20).  Although prenatal intake of methyl-donor micronutrients was not related to 
global DNA methylation in either study, Fryer et al. noted an inverse association between 
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homocysteine and DNA methylation in cord blood (20).  This was expected since 
elevated homocysteine may reflect a reduced systemic methylation capacity (21); yet, 
some animal (22) and human (23) studies have also reported no association between 
homocysteine and global DNA methylation. The conflicting literature underscores the 
need to elucidate how micronutrients involved in one-carbon metabolic pathways and 
plasma homocysteine levels are related to global DNA methylation in a population at risk 
of CVD.   
We examined the associations of daily folate, vitamin B12, vitamin B6, 
methionine, and zinc intake, and total plasma homocysteine with global DNA 
methylation using data from the MESA Stress Study, a subsample of healthy adults aged 






This cross-sectional investigation uses data collected by the MESA Stress Study, 
and ancillary study to the Multi-Ethnic Study of Atherosclerosis (MESA). MESA is a 
longitudinal investigation initiated in July 2000 in six U.S. cities to investigate the 
prevalence and progression of subclinical CVD. Details of the MESA sampling and 
recruitment procedures have been previously reported (24). The MESA Stress Study 
sampled 1002 MESA participants enrolled at the New York and Los Angeles sites. 
Participants were recruited in conjunction with the third and fourth follow-up exams of 
the full MESA; participant enrollment proceeded in the order in which they attended the 
follow-up exam.  At each field center, enrollment continued until approximately 500 
participants were enrolled.  All data used in these analyses was obtained from the MESA 
baseline examination conducted between 2000 and 2002. Anthropometric measurements 
including height and weight were obtained as part of the baseline examination.  
Participants also completed a set of subclinical cardiovascular disease measurements, as 
well as a comprehensive questionnaire to obtain information on sociodemographic 
characteristics, standard cardiovascular disease risk factors, lifestyle, and psychosocial 
factors. Physical activity was measured using a detailed, semiquantitative questionnaire 
adapted from the Cross-Cultural Activity Participation Study (B. Ainsworth, University 
of South Carolina, personal communication, 2000).  All procedures were carried out with 
written consent of the subjects.   
           Sociodemographic characteristics of the MESA Stress participants were similar to 
the large MESA cohort at the two participating sites with the exceptions that the 
22 
 
subsample had fewer individuals aged 75-84 (12.1% vs. 18.2%), more men (47.6% vs. 
44.7%) and more college-educated participants (29.7% vs. 23.9%).  
Dietary Assessment 
At the baseline examination, each participant completed a 120-item food-
frequency questionnaire (FFQ) (25) that was modified to include typical Chinese and 
Hispanic ethnic foods to accommodate the MESA subject population.  The FFQ inquired 
about serving size (small, medium, or large) and frequency of intake (times per day) for 
selected foods and beverages; nine frequency options were given that ranged from “rare 
or never” to a maximum of “≥ 2 times/day” for foods and a maximum of “≥ 6 
times/day” for beverages.  A section of the questionnaire included information on 
frequency, dosage, and duration of supplement use, allowing quantification of nutrient 
intake from supplements. Daily nutrient intakes from foods were estimated by 
multiplying the reported amount of food or beverage consumed (frequency x serving 
size) by its nutrient content (Nutrition Data Systems for Research [NDS-R]; University of 
Minnesota; Minneapolis).  For folate, nutrient content from foods was converted to 
dietary folate equivalent (DFE) units to account for differences in absorption of naturally 
occurring dietary folate and the more bioavailable synthetic folic acid.  All nutrients were 
adjusted for total energy intake using the residual method (26).  In the analyses, we 
considered total nutrient intake, intake from foods alone, and intake from supplements 
alone.  Values of extreme nutrient intake values (> 13,000 μg/d of folate, > 7000 μg/d of 
vitamin B12, > 180,000 mg/day of vitamin B6, or > 2000 mg/d of zinc), or extreme total 





          Phlebotomists obtained approximately 80 mL of blood from all participants in the 
fasting state at the baseline examination. Standardized methods were used to process and 
ship samples to a central laboratory (Laboratory for Clinical Biochemistry Research, 
University of Vermont, Burlington, Vermont).  Plasma was separated in an aliquot for 
homocysteine determinations. Total plasma homocysteine concentration was measured 
with a fluorescence polarization immunoassay (IMx Homocysteine Assay, Axis 
Biochemicals ASA, Oslo, Norway) with use of the the IMx analyzer (Abbott Diagnostics, 
Abbott Park, Illinois). The method is based on the enzymatic conversion of free 
homocysteine to S-adenosyl-L-homocysteine, which is subsequently detected by a 
competitive immunoassay.  The laboratory analytical coefficient of variation (CV) range 
was 4.5%. The detection range for this assay is 0.5 – 50.0 μmol/L.  
LINE-1 and Alu DNA Methylation Determinations 
We quantified methylation of two repetitive and dispersed elements, LINE-1 and 
Alu, as measures of global DNA methylation.  Together, LINE-1 and Alu comprise 
roughly 30% of the human genome and are valid measures of genomic methylation 
content (27, 28). High-molecular-weight DNA was extracted with commercially 
available PureGene Kits (Gentra Systems, Minneapolis, MN) from the leukocytes of 
blood collected at the baseline exam.  Approximately 200 ng of DNA at 10 ng/μl were 
bisulfite-treated using the EZ-96 DNA Methylation Kit™ (Zymo Research, Orange, CA).  
Bisulfite conversion of DNA deaminates unmethylated cytosine to uracil, which is read 
as thymidine during polymerase chain reaction (PCR). Methylated cytosines (5-
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methylcytosine) are protected from bisulfite conversion and thus remain unchanged, 
resulting in genome-wide methylation-dependent differences in DNA sequences.   
Pyrosequencing-based methylation analysis was used to quantify methylation at 
four genomic LINE-1 sites and three genomic Alu sites using previously described 
methods (29).  Global DNA methylation was assessed through simultaneous PCR of 
LINE-1 and Alu elements, using primers designated towards consensus LINE-1 and Alu 
sequences to allow for amplification of a representative pool of repetitive elements. The 
percentage of 5-methylated cytosines (%5-methylcytosine; %5mC) for each CpG target 
region was quantified using the Pyro Q-CpG Software. This software assigns quality 
scores for each measurement and internal quality controls to assess the efficiency of 
bisulfite conversion.  The interassay CV for LINE-1 and Alu was 2.10% and 5.73%, 
respectively. 
Statistical Analysis 
Of the 1002 participants in the MESA Stress study, information on LINE-1 and 
Alu methylation was available for 961 and 987 individuals, respectively.   All 
participants had data on at least one exposure of interest (daily intake of folate, vitamin 
B12, vitamin B6, zinc, or methionine; or total plasma homocysteine concentrations) and 
were included in the analyses.   
We first evaluated the distributions and correlations of %5mC for the four 
genomic LINE-1 sites and the three genomic Alu sites. The mean ± SD %5mC for the 
four LINE-1 sites was 79.91 ± 2.81, 81.91 ± 1.62, 76.93 ± 2.48, and 84.14 ± 2.48. For the 
three Alu sites, mean ± SD %5mC was 31.82 ± 1.55, 26.40 ± 1.61, and 15.07 ± 1.03. The 
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Spearman’s correlation coefficient ranged from 0.06 to 0.56 for LINE-1 sites and from 
0.44 to 0.66 for the Alu sites.  Because the distributions and correlations of %5mC 
differed by site for both measures of genomic methylation, mixed effects linear 
regression models were used to derive a single estimate of LINE-1 and Alu for each 
individual.  In these models, LINE-1 or Alu at each site were the dependent variables.  
Models included a random intercept for each site that was allowed to vary from person to 
person. The empirical best linear unbiased predictors (EBLUPs) obtained from the 
random effects represent the between-person variation in DNA methylation.  The final 
person-specific LINE-1 and Alu methylation variables were calculated by adding these 
EBLUPS to the raw average %5mC across the four sites for LINE-1, and across the three 
sites for Alu for the entire population. This method enabled us to incorporate the 
between-person variability of the underlying means for each LINE-1 and Alu site.   
Next, we examined the distribution of LINE-1 and Alu methylation separately 
across quartiles of homocysteine, as well as by categories of potential confounding 
variables that included sociodemographic, anthropometric, and lifestyle characteristics. 
Categories of body mass index (BMI) were created according to the World Health 
Organization (WHO) international classification of adult weight status (30). Alcohol and 
cigarette use were categorized as “never user”, “former user”, and “current user.”  A 
four-level income/wealth index was used as an indicator of socioeconomic status (SES). 
The variable was created using total family income and a 5-point wealth index used in 
prior MESA studies (31). The income component of the index was based on a 5-level 
income variable created from continuous family income of the participants. The wealth 
index is a 5-point variable based on ownership of assets including a car, a home, land, 
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and investments.  Thus, the income/wealth index is a sum of the income and wealth 
components that ranges from 0 to 8. In this analysis, the income/wealth index was 
categorized into 4 levels: 0-2 (lowest), 3-4, 5-6, and 7-8 (highest). Daily physical activity 
level was categorized into quartiles based on total hours of physical activity per week. 
We also compared DNA methylation with respect to cancer status, a dichotomous 
variable defined as “Yes” if the participant had ever been informed by a physician that 
they had cancer.  We assessed the statistical significance of differences in DNA 
methylation across categories of these variables with the use of linear regression models 
in which LINE-1 or Alu methylation was the outcome and predictors included indicator 
variables for each characteristic.  For ordinal characteristics, we obtained a test of linear 
trend.  
Next, we compared the distribution of LINE-1 and Alu methylation by energy-
adjusted quartiles of total nutrient intake, nutrient intake from foods only, and nutrient 
intake from supplements only for folate, vitamin B12, vitamin B6, and zinc (for intake 
category cut points, see Table 1.1).  Quartiles of micronutrient intake from foods only 
were estimated in the subpopulation of participants who did not use supplements because 
effects of nutrients from foods may be overpowered by the relatively high levels of 
intakes from supplements (26).  A test for linear trend was obtained for each intake 
variable. 
Finally, we conducted multivariable linear regression with the micronutrient 
intake and sociodemographic, anthropometric, and lifestyle variables that were related to 
DNA methylation based on prior knowledge, or were significantly related to LINE-1 or 
Alu methylation in the univariate analysis at P < 0.10.  The estimates for micronutrient 
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intake were not adjusted for homocysteine, as it could be on the causal pathway between 
nutrient intake and DNA methylation.  A test for linear trend was obtained for ordinal 
characteristics by introducing into the model a continuous variable representing the 
ordinal categories of the predictor.  For continuous variables, estimates were obtained for 
a difference in %5mC associated with a one standard deviation difference in the variable 
of interest (per 5 kg/m2 BMI, per 10 cm height, and per 3 μmol/L homocysteine). To 
determine whether the associations varied by sex, we tested for interactions with use of 
the likelihood ratio test.  We found no evidence that associations with LINE-1 or Alu 
methylation differed by sex; thus, results reported pool men and women and are adjusted 
for sex.    
           All analyses were carried out with the use of the Statistical Analyses System 









Mean ± SD age of the 987 participants was 61.4 ± 9.9 years; 47.5% were men.  
The overall mean ± SD DNA methylation was 82.73 ± 1.07 %5mC for LINE-1 and 24.42 
± 0.85 %5mC for Alu.  The correlation (Spearman’s ρ) between LINE-1 and Alu 
methylation was 0.15. 
Men had an average 0.40 %5mC higher LINE-1 methylation than women (P < 
0.0001), whereas Alu methylation did not differ by sex (Table 1.2).  Age was positively 
associated with LINE-1 methylation (P trend = 0.07).  DNA methylation differed 
significantly by race; compared to Whites, African Americans and Hispanics had 0.34 
%5mC and 0.24 %5mC higher LINE-1 methylation, respectively.  On the other hand, Alu 
methylation for African Americans and Hispanics was 0.20 %5mC and 0.23 %5mC 
lower than Whites, respectively.  A higher income/wealth index score was related to 
lower LINE-1 methylation (P trend = 0.04) and higher Alu methylation (P trend = 0.002).  
Height was positively correlated with both LINE-1 (P trend = 0.001) and Alu methylation 
(P trend = 0.12).  Higher BMI and homocysteine were both associated with higher LINE-
1 methylation (P trend = 0.06 and P trend = 0.0009, respectively). Never and former 
alcohol users had lower LINE-1 methylation than current alcohol users (P = 0.06).  
Physical activity was positively associated with Alu methylation (P trend = 0.06).  
Individuals who reported a history of cancer had 0.20 %5mC lower LINE-1 methylation 
than those who did not report cancer (P = 0.09). 
We did not find statistically significant associations between micronutrient intake 
and LINE-1 methylation (Table 1.3). However, there was a positive association of total 
vitamin B12 intake and total zinc intake with Alu methylation (Table 1.4).  Men and 
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women in the highest quartile of total vitamin B12 had 0.21 %5mC higher Alu 
methylation than those in the first quartile (P = 0.008).  Similarly, those in the highest 
quartile of total zinc intake had 0.16 %5mC higher Alu methylation than those in the 
lowest quartile (P = 0.05).  
We next examined the adjusted associations of homocysteine with LINE-1 
methylation using multivariable linear regression (Table 1.5).  After adjustment for 
covariates including sex, age, height, BMI, race, alcohol use, self-reported history of 
cancer, and income/wealth index, BMI remained positively associated with LINE-1 
methylation; each 5 unit difference in BMI was associated with a 0.06 %5mC higher 
LINE-1 methylation (P = 0.04).  We also observed a marginally statistically significant 
positive association between homocysteine and LINE-1 methylation.  Each 3 umol/L 
difference in homocysteine was related to a 0.06 %5mC higher LINE-1 methylation (P = 
0.07). 
Finally, we examined the associations of vitamin B12 intake, total zinc intake, 
and homocysteine with Alu methylation with use of a multivariable model that also 
included age, sex, height, race, height, income/wealth index; the models for vitamin B12 
and zinc did not include homocysteine because it may be on the causal pathway of 
micronutrient intake and DNA methylation (Table 1.6).  The positive associations of zinc 
and vitamin B12 intake with Alu methylation were attenuated and became statistically 
insignificant after multivariable adjustment. Height remained positively associated with 
Alu methylation; each 10 cm difference in height was associated with a 0.10 %5mC 





In this study of healthy adults aged 45-84 y, intake of methyl-donor and 
methylation cofactor micronutrients was not associated with global DNA methylation.  
However, we found positive associations of BMI and total plasma homocysteine with 
LINE-1methylation.  We also observed a positive relation between height and Alu 
methylation.  Although the differences in LINE-1 and Alu methylation were small, they 
represent changes at a global level that likely reflect larger differences in the context of 
the entire genome. 
Our finding of a positive relation between BMI and LINE-1 methylation 
contributes to the ongoing discussion regarding the role of DNA methylation in obesity-
related disease etiology.  Studies from the Dutch Winter Famine Cohort reported that 
periconceptional famine exposure was related to persistent changes in methylation of 
genes involved in cardiometabolic diseases (32, 33), as well as higher BMI and waist 
circumference in middle age (34).  While such findings suggest that aberrant DNA 
methylation is related to excess weight, current evidence on the association of BMI with 
global DNA methylation from cross-sectional studies in adults have been mixed (35-37). 
A recent cohort study conducted among 286 Singaporean-Chinese adults reported a 
positive association between global DNA methylation and BMI at baseline among both 
men and women (2).  Additionally, global DNA hypermethylation was associated with 
higher incidence of CVD (myocardial infarction, stroke) and its predisposing conditions 
(hypertension, diabetes) over the follow-up period among men only.  In the same study, 
DNA methylation did not differ by intake of folate or B vitamins, plasma folate levels, or 
folate-metabolizing genotypes (2),  leading the investigators to postulate that the 
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unexpected positive relations were driven by a mechanism independent of the DNA 
methylation pathway, such as systemic inflammation.  This hypothesis is lent support 
from a case-control study which showed that elevated C-reactive protein, an 
inflammation biomarker, was associated with global DNA hypermethylation in chronic 
kidney disease patients (38); yet, the opposite trend was observed in healthy school-age 
children (18).  While we cannot rule out the possibility that systematic inflammation may 
underlie the association observed in our study, it remains important to consider that 
global DNA hypermethylation could be a biomarker of adverse metabolic changes related 
to excess weight.  For example, researchers have identified differential methylation of 
several genes associated with weight-loss responsiveness to dieting, as well as changes in 
methylation in certain genes after weight loss (39).  Whether gene-specific changes 
manifest at the global level is not known; however, there is some evidence that prenatal 
exposures associated with gene-specific methylation are also related to global DNA 
methylation (40).  Further research is warranted to confirm the direction of the 
association between BMI and global DNA methylation, and longitudinal investigations 
are required to disentangle whether aberrations in DNA methylation patterns are a cause 
or consequence of weight gain. 
We also found a positive association between height and Alu methylation. This is 
a salient finding, as height is a sensitive indicator of early life exposures that otherwise 
may not be quantifiable.  Although some studies have examined associations of BMI with 
DNA methylation, the literature regarding height is scant. A recent study used data from 
two prospective birth cohorts to identify genes associated with high BMI, and to examine 
relations of gene-specific methylation in cord blood with BMI and its components at 9 y 
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(41).  After adjustment for multiple comparisons, the only association that remained 
apparent was a 0.15% lower height at 9 y for every 1 %5mC difference in DNA 
methylation of ALPL (41).  The ALPL gene encodes the alkaline phosphatase enzyme, 
which plays a critical role in bone mineralization; thus methylation silencing of ALPL 
could hinder skeletal growth.  Although this finding links gene-specific methylation to 
linear growth, changes at the global level are also important, as genomic methylation 
content has health implications beyond the function of one specific gene.  Smaller stature 
may be associated with lower global DNA methylation through exposure to adverse early 
life conditions, such as low socioeconomic status, which is related to shorter adult height 
(42), as well as lower DNA methylation (18).  Considering that height has been 
consistently inversely related to CVD risk (43, 44), understanding the biological 
mechanisms associated with poor linear growth would enhance knowledge of disease 
etiology and identify avenues for intervention. 
The marginally significant positive association between homocysteine and LINE-
1 methylation was unexpected.  During the DNA methylation cycle, the universal methyl-
donor SAM is de-methylated to S-adenosylhomocysteine (SAH), which is subsequently 
hydrolyzed to homocysteine.  Under optimal physiological conditions, homocysteine is 
re-methylated to methionine, which is then converted to SAM to provide the methyl 
group for subsequent methylation reactions.  Accordingly, a deficiency in methyl-donor 
micronutrients leads to increased plasma homocysteine and reversal of the SAH 
hydrolase reaction, resulting in accumulation of intra-cellular SAH, which was reported 
to decrease DNA methylation (45) since SAH is an inhibitor of the DNA methyl-
transferases (DNMTs) (46).  However, two human cases of SAH hydrolase deficiency 
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exhibited hypermethylated leukocyte DNA in comparison to controls, despite high levels 
of plasma SAH (47, 48).  Although the biological mechanism through which higher SAH 
would lead to increased global DNA methylation is unknown, it is important to note that 
the magnitude of the association we observed is quite small, and that only 3.7% (N = 35) 
of our study population is considered hyperhomocysteinemic according to the American 
Heart Association advisory statement (49).  It is possible that the expected inverse 
association between plasma homocysteine and DNA methylation would be observed if 
homocysteine levels were higher than those of our study population.  Future studies are 
required to better understand the kinetics of the methylation reaction in a population with 
a broader range of plasma homocysteine concentrations.   
Of note, we did not observe any associations of dietary micronutrient intake with 
LINE-1 or Alu methylation.  Although unexpected, the null findings are consistent with 
some studies in adults (12-14).  There are a few potential explanations for the lack of 
association between micronutrient intake and global DNA methylation in this study. 
First, due to folic acid fortification of the U.S. food supply, it is likely that few MESA 
participants were deficient in methyl-donor micronutrients; this speculation is further 
supported by the small proportion of hyperhomocysteinemic individuals in our study 
population.  A positive association of folate intake with global DNA methylation might 
be detectable in populations with a higher prevalence of methyl-donor micronutrient 
deficiencies.  Second, we only examined consumption of specific micronutrients, which 
does not account for the combinations of foods and nutrients that characterize the human 
diet. In a study of healthy adults, a prudent dietary pattern and consumption of green 
leafy vegetables was related to higher global DNA methylation, yet there were no 
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differences in DNA methylation by methyl-donor nutrient intake (16). Such findings 
suggest the involvement and interactions of multiple micronutrients and antioxidants in 
DNA methylation. Finally, although folate status (50, 51) and intake (52) have been 
positively related to DNA methylation, erythrocyte folate was not associated with global 
DNA methylation among school-age children (18), and folate intake was actually 
inversely related to DNA methylation in two other human studies (53, 54).  The folate 
pathway is not the only source of methyl groups for DNA methylation. Approximately 
60% of methyl groups are derived from choline in the liver (55);  thus choline-mediated 
homocysteine re-methylation may play a more important role in providing methyl groups 
for DNA methylation reactions.   Because we only had information on folate intake this 
population, we were not able to consider associations with choline.  Animal and human 
studies both indicate that the folate and choline transmethylation pathways are 
interrelated (56, 57); thus, it will be important to examine associations of both 
micronutrients with DNA methylation in future research.  
The discrepancies in associations of LINE-1 and Alu methylation with 
sociodemographic and dietary factors are also noteworthy. Repetitive elements are 
interspersed throughout the genome and are sensitive to environmental exposures, 
making them attractive surrogates of global DNA methylation in epidemiologic studies. 
Yet, there is considerable study-to-study variation with respect to the degree of 
correlation between the two assays, and the accuracy with which each measure 
approximates total genomic methylation content.  A recent study that compared 
methylation of LINE-1 and Alu with three other representative and dispersed sequences 
(strong CpG islands, weak CpG islands, and non-islands) in a set of placental chorionic 
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villi at three gestational ages (1st trimester, 2nd trimester, and at term) and in four somatic 
tissues (fetal brain, fetal kidney, fetal muscle and adult blood) showed that LINE-1 and 
Alu followed distinct methylation patterns from each other (58).  While LINE-1 
methylation varied across the different tissue types, there were no significant differences 
in Alu methylation.  Furthermore, the methylation pattern of LINE-1 was most similar to 
those of weak CpG island and non-island sequences, which are highly methylated CpG 
regions with no active role in transcriptional regulation (59).  LINE-1 sequences are sites 
of de novo DNA methylation during embryogenesis and are typically concentrated in low 
guanine-cytosine (GC) content regions.  Gene silencing through DNA methylation 
spreads from LINE-1 sequences to transcription start sites (TSS) (60),  a phenomenon 
that is thought to be buffered by Alu elements, which tend to cluster around TSS 
associated with CpG islands (61). Taken together, the evidence suggests that LINE-1 and 
Alu are functionally different, in addition to exhibiting unique dispersion patterns. There 
is need to characterize shared and exclusive environmental predictors of LINE-1 and Alu 
methylation, how modification of these predictors affects methylation of repetitive 
sequences, and the degree to which these changes influences disease risk. 
Our study had several strengths. We were able to examine LINE-1 and Alu 
methylation from circulating leukocytes in a large and ethnically diverse population of 
healthy adults.  LINE-1 and Alu methylation were determined using pyrosequencing 
technology, a highly reproducible and accurate method to quantify DNA methylation. 
Furthermore, quantifying DNA methylation from peripheral white blood cells is of high 
intrinsic value in epidemiologic studies, as it is easily obtained and reflects systemic 
interindividual variation in germ-layer cells (62).  We also used a culturally-tailored FFQ 
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to ascertain nutrient intake, which is the most appropriate method of dietary assessment 
in epidemiologic studies (26).  While use of a FFQ does not preclude the possibility of 
recall bias, it is an efficient and inexpensive measure of long-term dietary habits, which is 
more relevant to disease risk than short-term intake.  Because the FFQ ranks individuals 
within a population by their usual intake, it also is useful for nutrients with substantial 
day-to-day variation, including micronutrients. This study is limited by its cross-sectional 
design, which hampers the possibility of making causal inference on the predictors of 
global DNA methylation.   
In summary, we conclude that higher BMI and homocysteine levels are associated 
with higher LINE-1 methylation, whereas height is positively related to Alu methylation. 
The value of LINE-1 and Alu methylation as biomarkers of health outcomes requires 
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Table 1.1 Quartiles of nutrient intake in 987 MESA participants  
  Quartiles of energy-adjusted nutrient intake1 
  Q1                      Q2                      Q3                      Q4                      
Folate, μg 
    
 
n = 219 n = 221 n = 220 n = 219 
Total Intake < 299.9 299.9 - 406.6 406.7 - 974.9 > 974.9 
 
n = 147 n = 146 n = 147 n = 146 
From foods only < 278.1 278.1 - 331.7 331.8 - 401.1 > 401.1 
 
n = 690 n = 98 n = 98 n = 100 
From supplements only 0  > 0, < 768.5 768.5 - 832.9 > 832.9 
Vitamin B12, μg 
    
 
n = 219 n = 220 n = 221 n = 219 
Total < 2.4 2.4 - 3.9 4.0 - 12.8 > 12.8 
 
n = 139 n = 139 n = 139 n = 139 
From foods only < 1.94 1.94 - 2.72 2.73 - 3.65 > 3.65 
 
n = 660 n = 109 n = 108 n = 110 
From supplements 0 > 0, < 9.18 9.18 - 31.17 > 31.17 
Vitamin B6, mg 
    
 
n = 220 n = 220 n = 220 n = 220 
Total < 1.36 1.36 - 2.01 2.02 - 1982.24 > 1982.24 
 
n = 139 n = 139 n = 139 n = 140 
From foods only < 1.2 1.2 - 1.4 1.5 - 1.8 > 1.8 
 
n = 661 n = 107 n = 110 n = 109 
From supplements 0 >0, < 2007.7 2007.7 - 3952.9 > 3952.9 
Zinc,  mg 
    
 
n = 221 n = 221 n = 221 n = 220 
Total < 6.9 6.9 - 8.7 8.8 - 19.3 > 19.3 
 
n = 144 n = 144 n = 144 n = 144 
From foods only < 6.4 6.4 - 7.3 7.4 - 8.5 > 8.5 
 
n = 680 n = 101 n = 104 n = 102 
From supplements 0 > 0, < 14.8 14.8 - 15.6 > 15.6 
Methionine, g 
    
 
n = 221 n = 221 n = 220 n = 221 
Total Intake1 
< 1.03 1.03 - 1.23 1.24 - 1.43 > 1.43 




Table 1.2 Mean LINE-1 and Alu DNA methylation according to characteristics of MESA participants  
 
N2 LINE-1
1 P3  N2 Alu
1 P3 
 N = 961 N = 987 
Sex 
      M 457 80.94 (1.03) <0.0001 469 24.45 (0.81) 0.74 
F 504 80.54 (1.06) 518 24.42 (0.89) 
Age, years 
      45 - 54 290 80.66 (1.07) 
0.07 
298 24.43 (0.84) 
0.34 55 - 64 263 80.68 (1.09) 272 24.44 (0.86) 
65 - 74 292 80.81 (1.01) 299 24.31 (0.83) 
75 - 84 116 80.80 (1.15) 118 24.69 (0.83) 
Race 
      White, Caucasian 180 80.50 (1.21) 
0.008 
185 24.61 (0.96) 
0.01 Black, African-American 271 80.84 (0.98) 277 24.40 (0.79) 
Hispanic 510 80.75 (1.05) 525 24.38 (0.83) 
Education 
      Less than high school 257 80.72(1.09) 
0.41 
268 24.34 (0.85) 
0.29 High school 196 80.87 (1.07) 200 24.50 (0.83) 
Some college 287 80.65 (0.98) 293 24.46 (0.85) 
Bachelor's degree or higher 221 80.71 (1.13) 226 24.43 (0.86) 
Income/Wealth Index 
      0-2 (lowest) 311 80.82 (1.14) 
0.04 
324 24.33 (0.86) 
0.002 3-4 319 80.71 (0.96) 323 24.42 (0.81) 
5-6 202 80.71 (1.09) 207 24.51 (0.88) 
7-8 (highest) 126 80.57 (1.09) 130 24.56 (0.83) 
Height, cm 
      Q1: <162  239 80.57 (1.03) 
0.001 
243 24.41 (0.90) 
0.12 Q2: 162-165  241 80.65 (0.97) 250 24.34 (0.89) 
Q3: 165-172  240 80.85 (1.12) 246 24.45 (0.83) 
Q4: ≥ 172  241 80.84 (1.12) 248 24.50 (0.77) 
BMI,  kg/m2 
      < 25.0  220 80.67 (1.13) 
0.06 
231 24.37 (0.84) 
0.19 
25.0-29.0  382 80.71 (1.07) 392 24.42 (0.82) 
30.0-34.9  234 80.72 (1.05) 237 24.45 (0.90) 
35.0-39.9  79 80.86 (0.94) 81 24.62 (0.96) 
≥ 40.0 46 80.96 (1.01) 46 24.35 (0.67) 
Homocysteine, μmol/L 
      Q1: < 7.2 231 80.53 (1.09) 
0.0009 
240 24.53 (0.93) 
0.17 Q2: 7.2 - 8.5 231 80.75 (1.09) 235 24.40 (0.82) 
Q3: 8.6 - 10.2 256 80.75 (0.97) 263 24.39 (0.84) 
Q4: ≥ 10.3 242 80.88 (1.10) 248 24.41 (0.79) 
History of cancer 
      No 895 80.74 (1.08) 0.09 920 24.43 (0.85) 0.36 
Yes 63 80.54 (0.91) 64 24.34 (0.79) 
Cigarette Use 
      Never 504 80.66 (1.06) 
0.13 
520 24.45 (0.91) 
0.31 Current 346 80.81 (1.05) 354 24.43 (0.78) 
Former 111 80.75 (1.11) 112 24.33 (0.76) 
Alcohol Use 
      Never 201 80.60 (0.99) 
0.08 
191 24.44 (0.91) 
0.52 Current 242 80.81 (1.12) 225 24.38 (0.81) 
Former 517 80.74 (1.06) 465 24.45 (0.84) 
Daily Physical Activity Level 
      1 (lowest) 238 80.85 (1.08) 
0.19 
244 24.36 (0.83) 
0.06 2 231 80.69 (1.05) 239 24.36 (0.84) 
3 250 80.66 (0.99) 256 24.53 (0.85) 
4 (highest) 241 80.72 (1.13) 247 24.47 (0.88) 
1 From mixed effects linear regression models where site was treated as a random effect. 
2 Totals may be < 961 for LINE-1 and < 987 for Alu due to missing values. 
3 Test for linear trend for all variables except for sex, race, self-report cancer, alcohol use, and cigarette use (ANOVA). 
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Table 1.3  Mean percent LINE-1 methylation of leukocyte DNA by quartiles of micronutrient intake  
 
  
LINE-1 DNA Methylation by quartiles of energy-adjusted micronutrient intake                                                          
Mean (SD) %5mC 
  
  Q1      Q2          Q3                Q4            P2 
Folate      
Total Intake 80.78 (1.13) 80.57 (1.00) 80.90 (1.06) 80.74 (1.05) 0.53 
From foods only2 80.80 (1.12) 80.68 (1.04) 80.69 (1.10) 80.79 (1.04) 0.97 
From supplements only 80.74 (1.07) 80.75 (1.06) 80.84 (1.03) 80.69 (1.09) 0.95 
Vitamin B12      
Total Intake 80.70 (1.04) 80.81 (0.92) 80.74 (1.15) 80.74 (1.15) 0.90 
From foods only2 80.70 (0.93) 80.80 (0.97) 80.81 (1.01) 80.80 (1.19) 0.46 
From supplements only 80.78 (1.03) 80.60 (1.08) 80.89 (1.02) 80.59 (1.25) 0.33 
Vitamin B6      
Total Intake 80.70 (1.07) 80.73 (1.05) 80.79 (1.10) 80.78 (1.06) 0.38 
From foods only2 80.75 (0.98) 80.68 (1.07) 80.75 (1.07) 80.84 (1.04) 0.41 
From supplements only 80.76 (1.04) 80.64 (1.21) 80.91 (1.04) 80.63 (1.06) 0.74 
Zinc      
Total Intake 80.74 (0.99) 80.65 (1.07) 80.89 (1.09) 80.71 (1.10) 0.71 
From foods only2 80.80 (1.02) 80.70 (0.92) 80.73 (1.13) 80.77 (1.12) 0.91 
From supplements only 80.75 (1.05) 80.75 (1.03) 80.75 (1.11) 80.71 (1.17) 0.79 
Methionine      
Total Intake3 80.72 (1.09) 80.75 (1.05) 80.71 (1.05) 80.81 (1.08) 0.49 
            
1  Adjusted for total energy intake using the residual method. 
  
 
2  Represents a test for linear trend from univariate linear regression models where an ordinal variable for quartiles of the micronutrient 
was entered into the model as a continuous variable. 
3  From non-supplement users; n = 551 for folate, n = 522 for vitamin B12, n = 524 for vitamin B6, n = 542 for zinc. 
4  From foods only. 







Table 1.4 Mean percent Alu methylation of leukocyte DNA by quartiles of micronutrient intake  
  
Alu DNA Methylation by quartiles of energy-adjusted micronutrient intake                                                                 
Mean (SD) %5mC 
  
  Q1                        Q2                     Q3                     Q4                  P1 
Folate      
Total Intake 24.48 (0.87) 24.42 (0.92) 24.42 (0.77) 24.48 (0.83) 0.98 
From foods only2 24.41 (0.89) 24.46 (0.90) 24.53 (0.84) 24.36 (0.82) 0.81 
From supplements only 24.41 (0.86) 24.58 (0.86) 24.50 (0.81) 24.32 (0.77) 0.86 
Vitamin B12      
Total Intake 24.33 (0.80) 24.49 (0.89) 24.44 (0.88) 24.53 (0.81) 0.02 
From foods only2 24.31 (0.82) 24.50 (0.81) 24.35 (0.85) 24.49 (0.85) 0.27 
From supplements only 24.39 (0.85) 24.46 (0.87) 24.58 (0.79) 24.47 (0.85) 0.09 
Vitamin B6      
Total Intake 24.50 (0.88) 24.36 (0.87) 24.46 (0.83) 24.47 (0.81) 0.91 
From foods only2 24.54 (0.97) 24.31 (0.84) 24.43 (0.80) 24.43 (0.81) 0.56 
From supplements only 24.40 (0.85) 24.50 (0.92) 24.53 (0.78) 24.41 (0.80) 0.38 
Zinc      
Total Intake 24.37 (0.84) 24.44 (0.90) 24.44 (0.81) 24.54 (0.85) 0.06 
From foods only2 24.40 (0.88) 24.37 (0.85) 24.42 (0.85) 24.44 (0.84) 0.61 
From supplements only 24.39 (0.85) 24.43 (0.81) 24.61 (0.82) 24.50 (0.88) 0.01 
Methionine      
Total Intake3 24.44 (0.80) 24.42 (0.87) 24.50 (0.84) 24.43 (0.89) 0.88 
            
1  Test for linear trend from univariate linear regression models where an ordinal variable for quartiles of the micronutrient was 
entered into the model as a continuous variable.  
2  From non-supplement users; n = 566 for folate, n = 538 for vitamin B12, n = 538 for vitamin B6, n = 557 for zinc. 
3 From foods only. 





Table 1.5 Nutritional correlates of LINE-1 DNA methylation 





Height, per 10 cm 0.13 (0.06, 0.20)  0.02 (-0.08, 0.12) 
BMI, per 5 units 0.05 (0.00, 0.11)  0.06 (0.00, 0.12) 
Homocysteine, per 3 μmol/L 0.13 (0.07, 0.20)  0.06 (-0.01, 0.13) 
1 Multivariable model included sex, age, race, height, BMI, total plasma homocysteine, alcohol 




Table 1.6 Nutritional correlates of Alu DNA methylation 
 





Height, per 10 cm 0.04 (-0.02, 0.10) 
 
0.10 (0.02, 0.19) 
Homocysteine, per 3 μmol/L -0.04 (-0.09, 0.01)  -0.04 (-0.09, 0.02) 
Total vitamin B12 intake, μg3  
 
 
Q1: < 2.40 Reference 
 
Reference 
Q2: 2.40 - 4.02 0.16 (0.00, 0.33) 
 
0.14 (-0.02, 0.31) 
Q3: 4.03 - 12.77 0.12 (-0.04, 0.28) 
 
0.04 (-0.14, 0.22) 
Q4: ≥ 12.78 0.21 (0.05, 0.36) 
 




Total zinc intake, mg3  
 
 
Q1: < 6.89 Reference 
 
Reference 
Q2: 6.89 - 8.67 0.07 (-0.10, 0.23) 
 
0.03 (-0.14, 0.20) 
Q3: 8.68 - 19.30 0.07 (-0.09, 0.23) 
 
0.04 (-0.14, 0.21) 
Q4: ≥ 19.30 0.16 (0.00, 0.32) 
 




1 Multivariable model includes sex, age, height, total plasma homocysteine, total vitamin 
B12 intake, total zinc intake, race, physical activity level, and income/wealth index. Model 
for vitamin B12 and zinc intake does not include homocysteine 
2 Test for trend from a linear regression model where the outcome was Alu methylation and 
an ordinal indicator for the variable was entered as a continuous variable. 










Micronutrient status and global DNA methylation in school-age children 
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Introduction 
DNA methylation is a modifiable epigenetic mechanism that alters gene 
expression without changing the nucleotide sequence.  Aberrations in global DNA 
methylation patterns, as measured by methylation of long interspersed nucleotide element 
(LINE)-1 in peripheral white blood cells (WBC) (1, 2), have been related to risk of non-
communicable diseases including cancer (3, 4) and cardiovascular disease (5, 6);  
however, the mechanisms remain unclear. 
Methylation of LINE-1 repetitive elements is responsive to external cues 
including diet (7), prenatal exposures (8), and environmental agents (9).  Nutrition plays 
an important role in DNA methylation, as many dietary micronutrients are directly 
involved in DNA methylation pathways.  One-carbon metabolism, an essential metabolic 
process that ultimately provides the methyl group for DNA methylation reactions, 
requires adequate intake of methyl-donor nutrients such as folate, and methylation 
cofactors including vitamin B12 and zinc.  Although animal studies provide unequivocal 
evidence of the positive association between methyl-donor nutrient status and DNA 
methylation (10, 11), the evidence in humans is inconsistent and limited to adult 
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populations.  Some controlled-feeding trials showed changes in global DNA methylation 
in response to folate depletion (12, 13) and repletion (12), while other studies reported no 
difference in methylation after folate restriction or supplementation (14, 15).  A recent 
prospective study of maternal-infant dyads found no relations of periconceptional or 2nd 
trimester methyl-donor nutrient intake with cord blood LINE-1 methylation (16).  On the 
other hand, intake of folate-fortified foods was positively associated with LINE-1 
methylation in 165 cancer-free adults 18-78 years of age (17).  In another study of 
healthy adults, adherence to a prudent dietary pattern was related to lower prevalence of 
LINE-1 hypomethylation (7).  Furthermore, although the investigators found no 
difference in DNA methylation by methyl-donor nutrient intake, there was a positive 
correlation between consumption of dark green leafy vegetables and LINE-1 methylation 
(7).  This suggests that multiple micronutrients present in those vegetables, including 
folate and vitamins A, C, and K, could be involved in DNA methylation. For example,  in 
vitro treatment of human embryonic stem cells with retinoic acid (RA), a bioactive 
metabolite of vitamin A, influenced both global and gene-specific DNA methylation (18); 
yet, these associations have not been examined in epidemiologic studies.   
To date, there have not been any studies evaluating micronutrient status and 
global DNA methylation in pediatric populations.  In spite of current evidence that 
altered LINE-1 methylation is related to cardiometabolic risk factors that begin in early 
life such as atherosclerosis (19) and obesity (17), few factors are known to predict DNA 
methylation in children.  DNA methylation is fundamentally stable yet responsive to 
environmental exposures in the short term (9), thus identifying early correlates of global 
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DNA methylation would provide insight on disease etiology and inform preventive 
intervention efforts.  
In this study, we examined associations of micronutrient status biomarkers 
including erythrocyte folate; plasma vitamin B12, vitamin A, and ferritin, an indicator of 
iron status; and serum zinc concentrations with WBC LINE-1 methylation in 568 
children randomly selected from the Bogotá School Children Cohort (BSCC), an ongoing 





This study was conducted in the context of the Bogotá School Children Cohort 
(BSCC), a longitudinal investigation of nutrition and health among children from public 
schools in Bogotá, Colombia, ongoing since 2006.  Details of the study design have been 
previously reported (20). Briefly, we recruited a representative sample of 3,202 school 
children aged 5-12 years in February of 2006 from public schools in Bogotá, with use of 
a cluster sampling strategy.  The sample represents families from low- and middle-
income socioeconomic backgrounds in the city, as the public school system enrolls the 
majority of children from these groups (21). 
At the time of enrollment, comprehensive self-administered questionnaires were 
sent to parents and returned by 82% of households.  The questionnaires inquired about 
sociodemographic characteristics (including age, marital status, education level and 
socioeconomic level) as well as anthropometric measures of the mother (self-reported 
height and weight) and information about physical activity and sedentary habits of the 
child.  In the proceeding weeks, trained research assistants visited the schools to obtain 
anthropometric measurements and a fasting blood sample from the children.  Height was 
measured without shoes to the nearest 1 mm using a wall-mounted portable Seca 202 
stadiometer, and weight was measured in light clothing to the nearest 0.1 kg on Tanita 
HS301 solar-powered electronic scales according to standard protocols (22).  The parents 
or primary caregivers of all children gave written informed consent prior to enrollment 
into the study.  The study protocol was approved by the Ethics Committee of the National 
University of Colombia Medical School; the Institutional Review Board at the University 




At the baseline assessment, phlebotomists obtained a blood sample from the 
children’s antecubital vein after an overnight fast.  Samples were collected in EDTA 
tubes and transported the same day on ice and protected from sunlight to the National 
Institute of Health in Bogotá.  A complete blood count was carried out and plasma was 
separated into an aliquot for vitamin B12, C-reactive protein (CRP), and retinol 
determinations.  Vitamin B12 concentrations were measured using a competitive 
chemiluminescent immunoassay in an ADVIA Centaur analyzer (Bayer Diagnostics).  
CRP was measured with the use of a turbidimetric immunoassay on an ACS180 analyzer 
(Bayer Diagnostics).  Retinol was measured using high-performance liquid 
chromatography on a Waters 600 System.  Another aliquot was collected on a metal-free 
polypropylene BD tube without anticoagulant for determination of zinc concentrations 
according to the atomic absorption technique described by Makino and Takahara (23) on 
a Shimadzu AA6300 spectrophotometer.  Erythrocyte folate was measured on red blood 
cell lysates with the use of chemiluminescent immunoassay after the packed red cell 
volume was hemolyzed by dilution in a hypotonic aqueous solution of 1% ascorbic acid.  
All samples were measured in duplicate.  DNA was isolated from the buffy coat using the 
QIAmp DNA Blood Mini Kit (Qiagen, catalogue #: 51104, 51106) and cryopreserved 
until transportation to the University of Michigan for analyses. 
LINE-1 DNA Methylation Determinations 
Pyrosequencing-based DNA methylation analysis was carried out according to 
previously described methods (24).  Approximately 500 ng of DNA was bisulfite 
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converted using the EpiTect Bisulfite Kit (Qiagen, catalogue #: 59110, 59104).  Bisulfite 
conversion of DNA deaminates unmethylated cytosine to uracil, which is read as a 
thymidine during polymerase chain reaction (PCR). Methylated cytosines (5-
methylcytosine) are protected from bisulfite conversion and thus remain unchanged, 
resulting in genome-wide methylation-dependent differences in DNA sequence. Global 
DNA methylation was assessed through simultaneous PCR of the DNA LINE-1 
elements, using primers designed towards consensus LINE-1 sequences that allow for the 
amplification of a representative pool of repetitive elements. PyroQ-CpG software 
(Qiagen) was used to estimate the degree of methylation as the percentage of 5-
methylcytosine (%5mC) computed over the sum of methylated and unmethylated 
cytosines of four LINE-1 CpG sites.  All assays, starting with the bisulfite conversion, 
were run in duplicate.  %5mC site measurements that were more than 5 standard 
deviations above or below the raw mean LINE-1 methylation (< 69 or > 91 %5mC) were 
excluded from the analyses. 
Data Analyses 
Specimens were collected in 2816 (88%) of cohort participants.  We selected a 
random sample of 600 children for LINE-1 methylation determinations.  Of them, 568 
children had adequate DNA concentrations and constituted the final study population.  
These children did not differ from the rest of the BSCC in terms of nutritional status or 
sociodemographic characteristics. 
We first evaluated whether LINE-1 methylation means, variances, and 
correlations differed significantly by site and run.  Within-site correlations of duplicate 
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runs were high, thus the average %5mC for each site was obtained across duplicate runs.  
We then used mixed effects linear regression models to estimate overall LINE-1 DNA 
methylation assuming that each site’s estimate represented an independent underlying 
distribution.  In these models, individual intercepts for site were random effects.  The 
final LINE-1 methylation variable was calculated by adding these random effects 
(effectively, the between-subject variation in LINE-1 methylation) to the average %5mC 
across the four sites.  This method enables us to incorporate the between-person 
variability of the underlying means for each LINE-1 site. 
Next, we examined the distribution of LINE-1 methylation across categories of 
potential confounding characteristics for all children and separately by sex.  Predictors 
included sociodemographic and maternal characteristics, child’s anthropometric status, 
and CRP concentrations, a biomarker of inflammation.  Maternal body mass index (BMI) 
was calculated from measured height and weight in 26% of the mothers and from self-
reported data otherwise.  Maternal weight status was classified according to BMI 
categories as underweight (<18.5), adequate (18.5-24.9), overweight (25.0-29.9), or 
obese (≥30) (25).  Household socioeconomic stratum corresponded to the local 
government’s classification assigned to each household for planning and tax purposes.  
Children’s BMI-for-age and height-for-age Z-scores were calculated with use of the sex-
specific growth references for children 5-19 years from the World Health Organization 
(26).  CRP was dichotomized at the median value (<1.0 mg/L and ≥1.0 mg/L). The 
statistical significance of these associations was tested with use of univariate linear 
regression models in which LINE-1 methylation was the outcome, while predictors 
included indicator variables for each characteristic.  For ordinal predictors, we obtained a 
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test of trend. Robust estimates of variance were included in all models to overcome 
potential deviations from the multivariate normal. 
Next, we examined the associations of micronutrient status biomarkers and LINE-
1 methylation for all children and separately by sex.  The micronutrient biomarkers were 
categorized into quartiles, with the exception of vitamin A (categorized as < 0.700 
μmol/L, 0.700 – 1.049 μmol/L,  or ≥ 1.050 μmol/L) (27).  We estimated differences and 
95% confidence intervals (95% CI) in %5mC by categories of each micronutrient 
biomarker using linear regression models. 
Finally, we conducted multivariable linear regression with the micronutrient 
biomarkers and predictors that were significantly related to LINE-1 methylation in the 
univariate analysis at P < 0.10.  Due to potential threshold effects of maternal BMI and 
household socioeconomic stratum observed in the univariate analysis, we also considered 
dichotomous indicators of these variables (maternal BMI < 18.5 kg/m2 vs  ≥ 18.5 kg/m2, 
and household socioeconomic strata 1-3 vs 4).  Variables that remained significantly 
associated with the outcome at P < 0.05 were retained in the final model. A test for linear 
trend was obtained for ordinal characteristics by introducing into the model a continuous 
variable representing the ordinal categories of the predictor.  To determine whether the 
associations varied by sex, we tested for interactions with use of the likelihood ratio test.  
We found no evidence that associations with LINE-1 methylation differed by sex; thus, 
the final model is presented for both boys and girls. 
All analyses were carried out with the use of the Statistical Analyses System 




Mean ± SD age of children was 8.8 ± 1.7 years; 46.3% were boys.  Overall mean 
± SD LINE-1 DNA methylation was 80.25 ± 0.65 %5mC.  We assessed LINE-1 
methylation at four genomic sites in duplicate. The duplicate runs within site were highly 
correlated, with Spearman’s ρ of 0.71, 0.74, 0.66, and 0.64 for sites 1 through 4, 
respectively (Table 2.1).  Average %5mC of duplicate runs within site were 81.74 ± 
2.72, 81.70 ± 2.99, 80.10 ± 2.99, and 77.43 ± 2.90 for sites 1 through 4, respectively.               
In bivariate analyses (Table 2.2), boys had a 0.22 %5mC higher DNA 
methylation than girls on average (P < 0.0001).  There was an inverse association 
between age and LINE-1 methylation in boys; however, it was only marginally 
significant (P = 0.08). Higher plasma CRP was related to lower LINE-1 methylation (P = 
0.01), although the association was stronger in girls than boys.  Maternal education was 
positively associated with LINE-1 methylation in boys only (P trend = 0.06).  Although 
no monotonic trend was observed between maternal BMI and LINE-1 methylation (Table 
2), children in the lowest category of maternal BMI had notably lower DNA methylation 
than those in the other three categories (P = 0.01).  Similarly, we did not observe a 
significant linear trend between household socioeconomic stratum and LINE-1 
methylation, yet there appeared to be a threshold effect; children in the highest stratum 
had higher LINE-1 methylation than those in the lower three strata (P = 0.0002). 
We next examined the associations of micronutrient biomarkers with DNA 
methylation (Table 2.3). Retinol concentrations were inversely related to LINE-1 
methylation (P trend = 0.002), especially among girls (P trend = 0.006).  DNA 
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methylation was not related to erythrocyte folate, serum zinc, plasma vitamin B12, or 
ferritin. 
Finally, we examined the independent associations of these factors with LINE-1 
methylation with the use of a multivariable linear regression model.  The variables 
retained in the model as predictors included sex, plasma vitamin A, CRP, maternal BMI,  
and household socioeconomic stratum (Table 2.4).  In the multivariable analysis, LINE-1 
methylation was 0.21 %5mC lower in girls than boys (P = 0.0007).  Plasma vitamin A 
and CRP were each inversely related to LINE-1 methylation, while maternal BMI and 
household socioeconomic stratum were both positively associated with LINE-1 
methylation.  Children with ≥ 1.05 μmol/L plasma vitamin A had 0.19 %5mC  lower 
LINE-1 methylation than those with < 0.70 μmol/L plasma vitamin A (P = 0.03).  
Likewise, children with plasma CRP ≥ 1 mg/L had a 0.12 %5mC lower LINE-1 
methylation than those with CRP < 1 mg/L (P = 0.04).  Children of mothers with BMI ≥ 
18.5 had an average 0.31 %5mC higher LINE-1 methylation than those of mothers with 
BMI < 18.5 (P = 0.04).  Similarly, those in the highest stratum of household 
socioeconomic status have a mean LINE-1 methylation 0.29 %5mC higher than those in 





We examined associations of micronutrient status biomarkers with WBC LINE-1 
DNA methylation in 568 children randomly selected from the BSCC, a representative 
cohort of low- to middle-income school-age children from Bogotá, Colombia.  In 
addition, we ascertained associations of LINE-1 methylation with child and maternal 
sociodemographic and anthropometric characteristics.  As previously reported in adults 
(28), boys had higher global DNA methylation than girls.  We also found that higher 
plasma levels of vitamin A and CRP were each related to lower LINE-1 methylation, 
while higher maternal BMI and household socioeconomic status were each related to 
higher DNA methylation.  Although the differences in LINE-1 methylation were small, 
they represent changes at a global level that likely reflect larger differences in the context 
of the entire genome. 
The inverse association we observed between plasma vitamin A and LINE-1 
methylation could be related to retinoid-mediated changes in the expression or activity of 
DNA methyltransferase (DNMT), the endogenous enzyme that catalyzes the methylation 
reaction.  Treatment of breast cancer cells with all trans retinoic acid (atRA), the most 
biologically active metabolite of vitamin A, and with a synthetic retinoid X receptor-
selective retinoid (9cUAB30) down-regulated DNMT gene expression and telomerase 
activity when administered individually and in combination (29).  The RA treatments 
also suppressed expression of hTERT, the catalytic component of telomerase that is 
paradoxically hypermethylated and highly expressed in cancer cells (30).  Because 
inhibition of DNA methylation in cancer cells down-regulated expression of hTERT, the 
authors postulated that the retinoid-induced reduction of DNMT gene expression and 
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subsequent decrease in hTERT promoter methylation is a likely mechanism for decreased 
telomerase activity in human breast cancer cells.  In another study, the ability of atRA to 
incite cellular senescence in a broad range of human cell lines was strongly correlated 
with its ability to activate tumor suppressor genes p17 and p21 through promoter 
hypomethylation (31).  Although the DNMT-inhibitory effects of RA treatment have only 
been examined in the context of chemoprevention and cancer therapies, it is plausible that 
they can influence global DNA methylation as well.  Further research is warranted to 
investigate the effects of changes in vitamin A status on global DNA methylation, and 
also to evaluate whether lower global DNA methylation is related to poor health 
outcomes in school-age children. 
We also found that higher CRP was related to lower LINE-1 methylation.  Low 
grade inflammation, characterized by elevated circulating CRP, is an established risk 
factor of CVD in adults (32), and global DNA methylation is increasingly recognized as a 
key mechanism involved in the pathogenesis of inflammation-mediated cardiovascular 
risk factors such as atherosclerosis (33).  While a few studies in adults have examined the 
relation between inflammation and global DNA methylation, the findings have not been 
cohesive. Elevated circulating vascular cell adhesion molecule 1 (VCAM-1), an 
endothelial marker found in atherosclerotic lesions, was related to LINE-1 
hypomethylation in a population-based study of community-dwelling elderly men, while 
no associations were observed with CRP (34).  Similarly, a recent study of 165 cancer-
free adults found no association between LINE-1 methylation and inflammation 
biomarkers including CRP (17).  However, high sensitivity CRP (hsCRP) was related to 
global DNA hypermethylation in chronic kidney disease patients (35).  Although there is 
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need to better understand the nature of this association in more diverse populations, our 
finding that higher CRP was related to lower LINE-1 methylation in school-age children 
has important implications for identifying the relation of DNA methylation with other 
early CVD risk factors.  
We observed a positive relation of maternal BMI with LINE-1 methylation.  
Specifically, children of underweight mothers (BMI < 18.5) had significantly lower 
global DNA methylation than those whose mothers were not underweight.  This is a 
salient finding, assuming that maternal BMI is consistent with pre-pregnancy BMI in this 
population.  A low pre-pregnancy BMI is related to low birth weight (36), which has 
been associated with decreased cord blood DNA methylation (37).  The periconceptional 
period represents a critical window in ontogenic development, and is characterized by 
responsiveness of DNA methylation patterns to nutritional and environmental exposures 
(38).  Studies using data from the Dutch famine cohort reported that periconceptional 
exposure to famine was related to an unfavorable cardiometabolic risk profile in 
adulthood (39), and persistent changes in methylation of genes involved in growth and 
metabolism (40, 41). While such findings suggest that aberrant DNA methylation could 
be a mechanistic link between maternal malnutrition and an adverse metabolic 
phenotype, it is not possible to parse out specific exposures due to the retrospective 
nature of the data.  Currently, the literature regarding the relation of maternal BMI with 
child global DNA methylation is limited.  However, two studies conducted in maternal-
child dyads have included data on pre-pregnancy BMI and cord blood LINE-1 
methylation (16, 42).  Although the associations were not statistically significant, higher 
pre-pregnancy BMI was related to higher cord blood DNA methylation in both studies.  
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The implications of the association observed in our study are contingent upon 
longitudinal studies to verify the correlation between cord blood and childhood DNA 
methylation.  Furthermore, whether associations of maternal BMI with child DNA 
methylation represent epigenetic “programming” related to later-life health outcomes 
requires further investigation.  
Finally, we found a positive association between household socioeconomic 
stratum and LINE-1 methylation.  Lower socioeconomic status is related to adverse 
prenatal exposures such as maternal cigarette smoking (43), as well as unhealthy lifestyle 
characteristics during childhood including decreased physical activity levels (44) and a 
tendency to consume a diet high in fats and sugars (45).  The trend we observed was in 
accordance with expectations, as each of the above factors has been related to lower 
global DNA methylation in adults (7, 8, 46). 
Of note, we did not find significant associations between LINE-1 methylation and 
erythrocyte folate.  A potential explanation for the lack of association could be that the 
BSCC is a folate-replete population, with less than 1% prevalence of folate deficiency 
(47).  Associations between folate status and LINE-1 methylation might be observable in 
populations with erythrocyte folate levels lower than those of our study population.  It is 
also possible that effects of methyl-donor nutrients on DNA methylation occur during 
intrauterine life; however, a perinatal study did not find any associations between 
maternal intake of methyl-donor nutrients, including folate, periconceptionally or during 
the 2nd trimester with cord blood LINE-1 methylation (16). 
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Our study has several strengths.  Many studies of diet and LINE-1 methylation 
had a small sample size and were underpowered to detect small differences in LINE-1 
methylation.  We were able to examine global DNA methylation in a large and 
representative sample of children from a setting where the increasing prevalence of 
cardiovascular risk factors, such as child overweight, is becoming a serious problem.  We 
determined LINE-1 methylation using pyrosequencing technology, a highly reproducible 
and accurate method to quantify DNA methylation.  Furthermore, we used DNA from 
peripheral WBC, which is of high intrinsic value in epidemiologic studies, as it is easily 
obtained and reflects systemic interindividual variation in germ-layer cells (48).  We also 
used valid biochemical indicators of micronutrient status, which is the most accurate 
method of ascertaining micronutrient intake.  In addition, all assays were run in duplicate 
to minimize variability and enhance accuracy.  Limitations of the study include its cross-
sectional design, which restricts the possibility of making causal inference on the 
predictors of global DNA methylation, and its generalizability to other ethnicities, as 
there is some evidence that Hispanics may have lower LINE-1 methylation than non-
Hispanic whites (28). 
In summary, global DNA methylation in school-age children was inversely 
related to female sex, plasma retinol, and CRP concentrations, and positively associated 
with maternal BMI and household socioeconomic stratum.  The value of LINE-1 DNA 
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%5MeC Run 1                       N=555 
Run 2                        
N=506  
Run 1                          
N=561 
Run 2                                                   
N=505  
Run 1        
N=559 
Run 2                           
N=499  
Run 1                                      
N=559 
Run 2                                           
N=504 
Mean ± SD         80.73 ± 3.08 82.53 ± 2.67  81.04 ± 3.46 82.95 ± 2.09  79.23 ± 3.34 81.22 ± 2.50  76.72 ± 3.02 77.70 ± 2.57 
Median                        
(Range) 
80.63              
(70.45-90.49) 
82.48                    
(75.08-90.45)  
82.09                                
(69.44-86.29) 
83.11                 
(70.03-90.11)  
79.94                      
(69.17-87.04) 
81.43                     
(69.17-90.24)  
76.47                        
(69.21-90.69) 
77.32                  
(70.13-90.67) 







ICC1 0.48   0.56   0.52   0.55 
1 Intraclass correlation coefficient. 







Table 2.2 LINE-1 DNA Methylation according to background characteristics of 568 school-age children from 
Bogotá, Colombia 
  LINE-1 DNA Methylation (%5mC)
2 
  N1 All  N1 Males N1 Females 
Overall 568 80.25 (0.65) 
    Child's Sex 
      F 305 80.15 (0.65) 
    M 263 80.37 (0.64) 
    P3 
 
< 0.0001 
    Age, years 
      5-6  96 80.19 (0.64) 43 80.42 (0.62) 53 80.01 (0.60) 
7-8  183 80.29 (0.58) 85 80.43 (0.55) 98 80.17 (0.58) 
9-10  238 80.27 (0.71) 108 80.36 (0.71) 130 80.19 (0.70) 








Child was born in Bogotá 
      Yes 467 80.26 (0.65) 212 80.39 (0.63) 255 80.15 (0.65) 








Birth weight, g 
      <2500 44 80.17 (0.77) 20 80.20 (0.61) 24 80.14 (0.90) 
2500-2999 110 80.28 (0.67) 41 80.49 (0.73) 69 80.16 (0.60) 
3000-3499 128 80.26 (0.66) 57 80.41 (0.57) 71 80.14 (0.70) 








Height-for-age Z score5 
      Less than -2.0 55 80.27 (0.69) 22 80.27 (0.64) 33 80.27 (0.73) 
-2.0 to < -1.0 176 80.29 (0.62) 90 80.40 (0.57) 86 80.17 (0.65) 
-1.0 to < 1.0 299 80.22 (0.69) 133 80.37 (0.70) 166 80.11 (0.65) 








BMI-for-age Z-score 5 
      Less than -2.0 10 80.41 (0.51) 5 80.39 (0.63) 5 80.43 (0.43) 
-2.0 to < -1.0 63 80.34 (0.68) 30 80.36 (0.64) 33 80.32 (0.72) 
-1.0 to < 1.0 371 80.22 (0.64) 160 80.36 (0.64) 211 80.11 (0.62) 
1.0 to < 2.0 92 80.31 (0.73) 46 80.42 (0.70) 46 80.19 (0.75) 









      < 1.0 279 80.32 (0.67) 143 80.42 (0.62) 136 80.21 (0.71) 









      Incomplete Primary  37 80.28 (0.62) 18 80.38 (0.52) 19 80.19 (0.70) 
Complete Primary 106 80.24 (0.67) 46 80.30 (0.66) 60 80.19 (0.68) 
Incomplete Secondary 128 80.20 (0.65) 60 80.30 (0.63) 68 80.11 (0.65) 
Complete Secondary 209 80.29 (0.65) 94 80.44 (0.65) 115 80.16 (0.63) 
University 33 80.39 (0.70) 15 80.71 (0.56) 18 80.13 (0.72) 




Table 2.2 (Continued) LINE-1 DNA Methylation according to background characteristics of 568 school-age 
children from Bogotá, Colombia 
  LINE-1 DNA Methylation (%5mC)
2 
  N1 All  N1 Males N1 Females 
Maternal Height, cm 
      <154  109 80.30 (0.63) 51 80.37 (0.65) 58 80.24 (0.62) 
154-157  133 80.21 (0.68) 60 80.36 (0.67) 73 80.09 (0.67) 
158-161  110 80.29 (0.70) 49 80.47 (0.65) 61 80.15 (0.72) 








Maternal BMI, kg/m2 
      <18.5 17 79.88 (0.66) 5 80.11 (0.82) 12 79.78 (0.59) 
18.5-24.9  289 80.27 (0.63) 124 80.39 (0.67) 165 80.19 (0.59) 
25.0-29.9 136 80.27 (0.67) 70 80.43 (0.64) 66 80.10 (0.65) 








Household Socioeconomic Stratum 6 
    1 (lowest) 44 80.35 (0.48) 23 80.40 (0.55) 21 80.29 (0.38) 
2 174 80.20 (0.67) 87 80.35 (0.68) 87 80.06 (0.63) 
3 305 80.21 (0.64) 123 80.32 (0.64) 182 80.13 (0.64) 
4 (highest) 45 80.62 (0.71) 30 80.62 (0.61) 15 80.62 (0.89) 
P trend4   0.15   0.30   0.27 
1 Totals may be <568 for all children, < 263 for males, and < 305 for females because of missing values. 
2 From mixed effects linear regression models where site was a random effect. 
3 From analysis of variance (ANOVA). 
4 From univariate regression models in which a variable representing the ordinal predictor was introduced as continuous. 
5 According to the World Health Organization 2007 Child-Growth Reference (26).  




Table 2.3 LINE-1 DNA Methylation according to micronutrient status in 568 school-age children from Bogotá, Colombia 
 








  Mean (SD) %5mC difference           (95% CI) Mean (SD) 
%5mC difference           
(95% CI) Mean (SD) 
%5mC difference           
(95% CI) 
Erythrocyte Folate, nmol/L 
        Q1 139 80.24 (0.61) Reference 64 80.32 (0.60) Reference 75 80.13 (0.59) Reference 
Q2 139 80.21 (0.64) -0.03 (-0.18, 0.11) 64 80.31 (0.65) -0.01 (-0.23, 0.20) 74 80.17 (0.66) 0.04 (-0.16, 0.24) 
Q3 139 80.25 (0.67) 0.01 (-0.14, 0.16) 65 80.41 (0.62) 0.09 (-0.11, 0.30) 75 80.11 (0.69) -0.02 (-0.23, 0.18) 








 Plasma Vitamin B12, pmol/L 
        Q1 137 80.30 (0.64) Reference 64 80.40 (0.69) Reference 72 80.19 (0.58) Reference 
Q2 136 80.26 (0.61) -0.04 (-0.19, 0.11) 63 80.41 (0.63) 0.01 (-0.22, 0.24) 72 80.13 (0.53) -0.06 (-0.24, 0.12) 
Q3 134 80.24 (0.66) -0.06 (-0.22, 0.09) 64 80.38 (0.63) -0.02 (-0.25, 0.21) 72 80.12 (0.69) -0.07 (-0.28, 0.14) 








 Serum Zinc, μmol/L 
        Q1 140 80.22 (0.66) Reference 66 80.33 (0.65) Reference 75 80.13 (0.64) Reference 
Q2 142 80.23 (0.64) 0.01 (-0.14, 0.16) 65 80.36 (0.65) 0.03 (-0.19, 0.25) 76 80.12 (0.63) -0.01 (-0.22, 0.19) 
Q3 141 80.30 (0.64) 0.07 (-0.08, 0.23) 65 80.43 (0.62) 0.10 (-0.11, 0.32) 75 80.16 (0.62) 0.03 (-0.17, 0.23) 








 Plasma ferritin, μg/L 
        Q1 141 80.34 (0.66) Reference 66 80.49 (0.65) Reference 75 80.17 (0.62) Reference 
Q2 139 80.18 (0.63) -0.16 (-0.31, -0.01) 66 80.35 (0.63) -0.14 (-0.35, 0.08) 76 80.10 (0.65) -0.07 (-0.27, 0.14) 
Q3 143 80.26 (0.64) -0.08 (-0.24, 0.07) 64 80.31 (0.61) -0.17 (-0.39, 0.04) 75 80.15 (0.63) -0.01 (-0.21, 0.19) 








 Plasma vitamin A, μmol/L 
        < 0.700 72 80.37 (0.63) Reference 34 80.40 (0.59) Reference 38 80.35 (0.67) Reference 
0.700 - 1.049 235 80.32 (0.63) -0.06 (-0.22, 0.11) 111 80.45 (0.67) 0.05 (-0.18, 0.29) 124 80.20 (0.57) -0.16 (-0.39, 0.07) 
≥ 1.050 260 80.16 (0.67) -0.22 (-0.38, -0.05) 118 80.29 (0.63) -0.10 (-0.33, 0.12) 142 80.04 (0.69) -0.31 (-0.55, -0.07) 
P trend3   0.002     0.13     0.006   
1 Totals may be <568 for all children, < 263 for males, and < 305 for females because of missing values. 
2 From mixed effects linear regression models where site was a random effect. 




Table 2.4 Correlates of LINE-1 DNA methylation in 568 school-age children 
from Bogotá, Colombia 
  Adjusted %5mC difference1 
 β (95% CI) 
Sex  
Male Reference 
Female -0.21 (-0.32, -0.09) 
P 0.0007 
Plasma vitamin A, μmol/L  
< 0.700 Reference 
0.700 - 1.049 -0.07 (-0.24, 0.10) 
≥ 1.050 -0.19 (-0.36, -0.02) 
P trend2 0.006 
C-reactive Protein, mg/L  
< 1.0  Reference 
≥ 1.0  -0.12 (-0.24, -0.01) 
P 0.04 
Maternal BMI, kg/m2  
< 18.5 Reference 
≥ 18.5  0.31 (0.01, 0.60) 
P 0.04 
Household Socioeconomic Stratum3  
1-3 (lower) Reference 
4    (highest) 0.29 (0.07, 0.51) 
P 0.01 
1 From a linear regression model with LINE-1 methylation as the outcome and predictors 
that included sex, vitamin A, CRP, maternal BMI, and household socioeconomic stratum. 
2 Test for linear trend from a linear regression model where an ordinal indicator for the 
variable was entered as a continuous predictor. 
















A prospective study of global DNA methylation and development of adiposity  
in school-age children  
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Ana Baylin, and Eduardo Villamor 
 
Introduction 
Childhood obesity has reached epidemic proportions worldwide. Of special 
concern are countries undergoing the nutrition transition, including Latin America, that 
have experienced a marked increase in pediatric obesity rates in the last two decades (1). 
Although researchers have identified dietary and lifestyle factors accountable for the 
rapid increase in childhood obesity, the biological mechanisms remain unclear. 
Epigenetic animal models indicate that maternal intake of methyl-donor micronutrients is 
protective against offspring obesity through increased DNA methylation in genomic 
regions that regulate satiety and metabolism (2-4).  Recent epidemiologic evidence 
suggests that aberrant changes in global DNA methylation quantified from peripheral 
white blood cells (WBC) are associated with prominent obesity-related diseases including 
cancer (5), diabetes (6), and cardiovascular disease (7-9). Yet, there is little research on 
the relation between global DNA methylation and weight status.   
Current evidence on global DNA methylation and body size consists mostly of 
mixed findings from cross-sectional studies in adult populations (8, 10-14). Some studies 
of maternal-infant dyads have been conducted to investigate relations of perinatal 
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characteristics, including birth weight, with cord blood DNA methylation (15-17). One 
study reported that high and low birth weight, as well as premature birth were associated 
with significantly lower cord blood DNA methylation (16).  However, inference from 
perinatal studies is limited because it is not known whether functional consequences of 
these associations contribute to obesity in later life. A recent study that used data from 
two independent birth cohorts identified nine differentially methylated genes quantified 
from cord blood at birth that were associated with body composition at 9 y (18).  While 
such findings shed light on regulatory pathways involved in weight gain, gene-specific 
methylation does not provide a global picture of methylation changes within the entire 
genome.  Genome-wide methylation is important to understand because it is responsive 
to environmental modifications (19), and because genomic stability has profound health 
implications beyond the specific function of a gene. Considering that early life weight 
status influences cardiometabolic morbidity in adulthood (20),  it is critical to identify 
molecular mechanisms involved in the etiology of childhood obesity. 
In this study, we examined the prospective relation of global DNA methylation at 
recruitment into a cohort, as measured by methylation of long interspersed nucleotide 
element (LINE)-1, with changes in adiposity and linear growth indicators in a 
representative group of low- and middle-income children from Bogotá, Colombia, a 





This study was conducted in the context of the Bogotá School Children Cohort 
(BSCC), a longitudinal investigation of nutrition and health among children from public 
schools in Bogotá, Colombia, ongoing since 2006.  Details of the study design have been 
previously reported (21). Briefly, we recruited a representative sample of 3,202 school 
children aged 5-12 y in February 2006 from public schools in Bogotá, using a random 
sampling strategy.  The sample represents families from low- and middle-income 
socioeconomic backgrounds in the city, as the public school system enrolls the majority 
of children from these groups (22). 
At the time of enrollment, comprehensive self-administered questionnaires were 
sent to parents and returned by 82% of households.  The questionnaires inquired about 
sociodemographic characteristics (including age, marital status, education, and 
socioeconomic level) as well as anthropometric measures of the mother (self-reported 
height and weight) and information about physical activity and sedentary habits of the 
child.  In the proceeding weeks, trained research assistants visited the schools to obtain 
anthropometric measurements and a fasting blood sample from the children.  Height was 
measured without shoes to the nearest 1 mm using a wall-mounted portable Seca 202 
stadiometer, and weight was measured in light clothing to the nearest 0.1 kg on Tanita 
HS301 solar-powered electronic scales. The subscapular and tricipital skinfold 
thicknesses were measured to the nearest 0.5 mm using Slim Guide Skinfold Calipers 
(Creative Health Products, Inc. Plymouth, MI) according to standard protocols (23).  
Follow-up anthropometric measurements were obtained in June and November 2006 and 
once yearly thereafter by visiting the schools or homes of the children when they were 
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absent from school on the day of assessment.  At these follow-up visits, we also 
measured waist circumference using a non-extensible measuring tape at the level of the 
umbilicus (23). 
The parents or primary caregivers of all children gave written informed consent 
prior to enrollment into the study.  The study protocol was approved by the Ethics 
Committee of the National University of Colombia Medical School. The Institutional 
Review Board at the University of Michigan approved the use of data and samples from 
the study. 
Laboratory Methods 
At the baseline assessment, phlebotomists obtained a blood sample from the 
children’s antecubital vein after an overnight fast.  Samples were collected in EDTA 
tubes and transported the same day on dry ice and protected from sunlight to the National 
Institute of Health in Bogotá.  A complete blood count was carried out and plasma was 
separated into an aliquot for micronutrient and inflammation biomarker determinations; 
details are described elsewhere (24).  DNA was isolated from the buffy coat using the 
QIAmp DNA Blood Mini Kit (Qiagen, Hilden, Germany) and cryopreserved until 
transportation to the University of Michigan for analyses. 
LINE-1 DNA Methylation Determinations 
Pyrosequencing-based DNA methylation analysis was carried out according to 
methods described by Tost and Gut (25).  Approximately 500 ng of DNA was bisulfite 
converted using the EpiTect Bisulfite Kit (Qiagen).  Bisulfite conversion of DNA 
deaminates unmethylated cytosine to uracil, which is read as a thymidine during 
polymerase chain reaction (PCR). Methylated cytosines (5-methylcytosine) are protected 
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from bisulfite conversion and thus remain unchanged, resulting in genome-wide 
methylation-dependent differences in DNA sequence. Global DNA methylation was 
assessed through simultaneous PCR of the DNA LINE-1 elements, using primers 
designed towards consensus LINE-1 sequences that allow for the amplification of a 
representative pool of repetitive elements. PyroQ-CpG software (Qiagen) was used to 
estimate the degree of methylation as the percentage of 5-methylcytosine (%5mC) 
computed over the sum of methylated and unmethylated cytosines of four LINE-1 CpG 
sites.  All assays, starting with the bisulfite conversion, were run in duplicate.  %5mC site 
measurements that were more than 5 standard deviations above or below the raw mean 
LINE-1 methylation (< 69 or > 91 %5mC) were excluded from the analyses.  
Statistical Analysis  
Specimens were collected in 2816 (88%) of cohort participants.  We selected a 
random sample of 600 children for LINE-1 methylation determinations; adequate DNA 
concentrations were available for 568 children.  Of them, 553 children who had valid 
anthropometric measurements at baseline and at least one additional follow-up 
measurement constituted the final study population.  These children did not differ from 
the rest of the BSCC in terms of nutritional status or sociodemographic characteristics at 
the baseline assessment. 
Because the distribution of %5mC at each LINE-1 site differed from individual to 
individual, we used a mixed effects linear regression model to create the final person-
specific LINE-1 methylation variable.  First, we took the average %5mC for each site 
across the duplicate runs since within-site correlations were high (24).  Next, we fit a 
mixed effects model that included a random intercept for %5mC methylation at each site 
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that was allowed to vary from person to person. Accordingly, the empirical best linear 
unbiased predictors (EBLUPs) from the random effects represent the between-person 
variation in DNA methylation. The EBLUPS were added to the population raw average 
%5mC across the four LINE-1 sites.  This method enabled us to incorporate the between-
person variability of the underlying means for each LINE-1 site.  
Next, we examined the relations of LINE-1 methylation with change in three 
indicators of adiposity:  BMI-for-age Z-score (BMIZ) as an indicator of overall 
adiposity;(26) waist circumference Z-score as an indicator of central adiposity (27); and 
subscapular-to-triceps skinfold thickness ratio Z-score as an indicator of truncal adiposity 
(28) over the 2.5 years of follow-up, separately for boys and girls. We also examined 
associations with height-for-age Z-score.  Children’s BMI-for-age and height-for-age Z-
scores were calculated with use of the sex-specific growth references for children 5-19 
years from the World Health Organization (29).  We age-standardized waist 
circumference and the subscapular-to-triceps skinfold thickness ratio with the LMS  
method (30) using data from children 5-16 y of age in the third National Health and 
Nutrition Examination Survey (NHANES III) (31).  The LMS method summarizes the 
distribution of each anthropometric measurement by its median (M) and coefficient of 
variation (S), plus a measure of skewness based on the Box-Cox power (L) to normalize 
data.  This approach is ideal for age-related standardization because it accounts for 
differential degrees of asymmetry in the distribution of an anthropometric measure within 
each stratum of age, rather than assuming the same skewness across age groups. We 
estimated mean changes in each of the adiposity indicators and height-for-age Z-score 
during follow-up and compared them across quartiles LINE-1 methylation with the use of 
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mixed effects linear regression models for repeated measures.  In each model, the 
anthropometric measurement was the outcome and the predictors included indicator 
variables for quartiles of LINE-1 methylation, age in decimal years, and interaction terms 
between the LINE-1 methylation indicator and age.  These mixed models included 
random effects for the intercept and slope; an unstructured variance-covariance matrix 
was specified to account for within-child correlations of anthropometric measurements. 
For the waist circumference model, random effects for the slope were not included 
because measurements were only obtained in the second and third years of follow-up; the 
change in waist circumference represented the change between the two measurements 
taken during follow-up.  These methods do not require an even number of observations or 
that measurements be collected at exactly the same time in all subjects, thus all 
measurements available for every child were included in the analyses. Because non-linear 
associations seemed apparent in preliminary analyses, we also examined associations 
with a dichotomous indicator that represented the 1st vs. 2-4th quartiles of LINE-1 
methylation. 
In the multivariable models, we considered adjustment by nutritional and 
sociodemographic covariates that are associated with LINE-1 methylation in this 
population (24), as well as known predictors of child growth.  Empirical estimates of 
variance were used in all models to overcome deviations from the multivariate normality 
assumption.  
All analyses were carried out with the use of the Statistical Analyses System 





Mean ± SD age of children was 8.8 ± 1.7 years; 45.9% were boys.  Each child 
contributed a median of 4 measurements for BMI, height, and the skinfold thicknesses, 
and a median of 2 measurements for waist circumference over a median of 30 months of 
follow-up (IQR = 29, 31). Prevalence of overweight/obesity at baseline was 9.8%. Boys 
had significantly higher LINE-1 methylation than girls (P < 0.0001; Table 3.1). 
Additional correlates of LINE-1 methylation in this population have been reported before 
(24).  
Among boys, LINE-1 methylation was not related to baseline BMI-for-age Z-
score or skinfold thickness ratio Z-score (P trend = 0.73 and P trend = 0.60, respectively).  
However, DNA methylation was inversely related to change in these indicators during 
follow-up in a non-linear manner (Table 3.2).  Boys in the lowest quartile of LINE-1 
methylation experienced annual gains in BMI-for-age Z-score and skinfold thickness 
ratio Z-score that were 0.06 Z/y (95% CI = -0.11, 0.00; P = 0.04) and 0.07 Z/y (95% CI = 
-0.13, -0.01; P = 0.03), respectively, higher than those in the upper three quartiles after 
adjustment for baseline age and socioeconomic status. Further adjustment for maternal 
BMI and plasma vitamin A did not change the direction, magnitude, or significance of 
the associations (data not shown).  In addition, LINE-1 DNA methylation was inversely 
associated with change in waist circumference Z-score in a linear fashion (P trend = 
0.02). Boys in the lowest quartile of LINE-1 methylation experienced a 0.09 Z/y greater 
annual gain in waist circumference than those in the highest quartile (P = 0.01).     
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There were no significant associations between LINE-1 methylation and any of 
the adiposity indicators at baseline, or over the follow-up period among girls (Table 3.3). 





 In this study of 553 school children from low- and middle-income families in 
Bogotá, Colombia, we found inverse associations of global DNA methylation at time of 
recruitment into the cohort with annual change in three age- and sex-standardized 
measures of adiposity (BMI-for-age Z-score, waist circumference-for-age Z-score, and 
subscapular-to-triceps skinfold thickness ratio-for-age Z-score) among boys. Because 
mean BMI of this population at baseline was higher than the international growth 
reference (29), these associations likely reflect unhealthy gains in adiposity.  
These findings contribute to the understanding of biological mechanisms that 
underlie childhood obesity.  Early life environmental stimuli could induce long-lasting 
changes in DNA methylation profiles that are related to obesity and cardiometabolic 
disease.  For example, middle-aged adults who were conceived during the Dutch Winter 
Famine exhibited persistent changes in methylation of genes involved in cardiometabolic 
diseases (32, 33) and had a higher BMI and waist circumference than their unexposed 
same-sex siblings (34).  The direct relation between DNA methylation and obesity has 
mostly been examined in cross-sectional studies of adults. A study conducted among 
middle-aged Samoan islanders reported that LINE-1 DNA methylation was positively 
correlated with BMI among women (8).  In a cohort of Singaporean Chinese adults, 
hypermethylation of the satellite repetitive element (AS) was associated with higher BMI 
at baseline in both men and women (11).  In the same study, higher AS methylation was 
related to incidence of cardiovascular disease over follow-up among men only (11). The 
authors postulated that global DNA hypermethylation could serve as a biomarker of 
cardiovascular disease risk and obesity; yet, the relation between AS methylation and 
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BMI was assessed only at baseline, making it impossible to determine whether higher 
DNA methylation preceded high BMI or vice versa.  Other cross-sectional studies have 
not found an association between DNA methylation and measures of adiposity in adults 
(10, 12-14, 35).  To date, the largest gap in this area of research is the lack of longitudinal 
investigations to assess the temporal relation of global DNA methylation with changes in 
anthropometry.  We were able to examine prospective changes in three indicators of 
adiposity with respect to global DNA methylation quantified from blood samples 
collected at baseline from a large and representative sample of school-age children. Our 
results indicate that global DNA hypomethylation is related to adverse weight gain 
patterns during the school years.  The fact that change in waist circumference was 
strongly associated with LINE-1 methylation is especially important because abdominal 
fat mass is an independent predictor of morbidity (36) and mortality (37) in adults. 
Furthermore, there is prospective evidence that accrual of central fat during childhood is 
related to adverse metabolic consequences in later life (38). Our findings also provide a 
basis for to further investigate molecular mechanisms involved in early life weight gain.  
Considering that adipocyte quantity is established sometime between late childhood and 
early adolescence (39), identifying modifiable pathways involved in adipogenesis during 
the school-age years would be particularly valuable to interventions efforts aimed at 
improving long term cardiometabolic health. 
The trend between LINE-1 methylation and the adiposity indicators was apparent 
among boys only.  It is uncertain whether this dichotomy is due to copy number variation 
in LINE-1 on the X and Y chromosomes, a sex hormone effect on methylation, or sex-
specific weight gain patterns.  We also noted that the association between LINE-1 DNA 
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methylation and change in anthropometry was in the opposite direction of what was 
observed in adults (8, 11).  This discrepancy could be attributed to differences in study 
design, as the adult studies were cross-sectional, which restricted inference on causation.  
There may also be inherent age-specific differences in epigenetic associations. For 
example, although studies in adults have reported inverse relations between age and 
global DNA methylation (10, 40), DNA methylation was not associated with age in our 
study population (24), or in a pilot study of girls 6-17 y in the US (41).  Because the 
epigenome reflects perinatal (42) and lifetime exposures (19, 43, 44), findings from 
children may not be directly comparable to adult studies.  Nevertheless, longitudinal 
studies in both adults and children will be useful to disentangle the nature of the relation 
between global DNA methylation and weight gain. 
There are a few pathways that may explain the associations observed in boys. The 
variability in methylation at the global level may reflect concomitant differences in gene-
specific methylation, as there is evidence that some prenatal exposures are associated 
with both gene-specific and global DNA methylation (45). Two recent prospective 
studies found significant associations between methylation of candidate genes quantified 
from cord blood at birth and childhood body size (18, 46).  Godfrey et al. reported that 
hypermethylation of the retinoid X receptor alpha (RXRA) promoter region was 
correlated with greater adiposity at age 9 in two independent birth cohorts (46). Because 
RXRA regulates transcriptional activity through heterodimerization with peroxisome 
proliferator-activated receptors (PPARs) directly involved in regulating insulin sensitivity 
and fat metabolism (47), hypermethylation silencing of RXRA could lead to weight gain. 
This hypothesis is consistent with the observation that RXRA expression in adipose tissue 
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of obese mice and humans is diminished (48). There is also increasing evidence from 
animal models that exposure to ubiquitous obesogenic chemicals, such as Bisphenol-A 
(BPA), can influence DNA methylation (3) and promote adipogenesis (49).  An in vitro 
study that examined omental adipose tissue biopsies from children demonstrated that 
exposure to environmentally relevant levels of BPA increased expression of PPAR-γ 
(50), a nuclear hormone receptor that stimulates fat cell differentiation. Taken together, 
these findings support the notion that DNA methylation and gene expression changes 
could precede alterations in body composition.  Whether modification of DNA 
methylation profiles through dietary interventions influences body composition deserves 
further investigation. 
We did not find any associations between LINE-1 methylation and linear growth.  
The lack of association could be related to the age distribution of the study population.  
Preliminary results in a U.S. birth cohort suggested that higher cord blood LINE-1 
methylation was related to greater childhood height up to 7 y among boys (51).  
However, the school-age years coincide with the pre-pubertal nadir, where linear growth 
velocity decelerates and reaches a minimum approximately two years prior to the 
adolescent height spurt, which occurs around 14 y in boys and 12 y in girls (52). Given 
that mean age at baseline in our cohort was 8.8 y, the follow-up period may not have 
been sufficient to capture substantial changes in height.  Long-term cohort studies 
examining the relation of global DNA methylation with linear growth beyond 
adolescences are warranted.  
Our study has several strengths.  We were able to examine global DNA 
methylation in a large and representative sample of children from a setting where the 
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increasing prevalence of childhood obesity is becoming a serious public health problem.  
The prospective design and use of repeated anthropometric measures enhanced our 
ability to explore the temporal relation between LINE-1 methylation and changes in body 
weight.  We also adjusted the estimates of association for key potential confounders, 
including baseline age and socioeconomic status.  LINE-1 methylation was determined 
using pyrosequencing technology, a highly reproducible and accurate method to quantify 
DNA methylation, with all assays run in duplicate to minimize variability and enhance 
accuracy.  Additionally, we used DNA from peripheral WBC, which is of high intrinsic 
value in epidemiologic studies as it is easily obtained and reflects systemic 
interindividual variation in germ-layer cells (53).  Limitations of the study include 
reliance on only one measurement of LINE-1 methylation at the time of enrollment, 
potential random measurement error in anthropometry, and generalizability to other 
ethnicities as there is some evidence that Hispanics may have lower LINE-1 methylation 
than non-Hispanic whites (12). 
We conclude that lower global DNA methylation is related to development of 
adiposity in school-age boys. Because global DNA methylation is responsive to external 
cues such as diet (54, 55), these findings are of particular relevance to nutrition 
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Table 3.1 Characteristics of 553 school-age children from Bogotá, Colombia1 
Characteristic2 All Children Boys Girls 
Sex, (N) 553 254 299 
Age, y 8.8 ± 1.7 8.9 ± 1.7 8.8 ± 1.7 
LINE-1 DNA methylation, %5mC 80.25 ± 1.55 80.53 ± 1.52 80.01 ± 1.54 
Child was born in Bogota, % (N) 90.5 (458) 90.8 (207) 90.3 (251) 
Birthweight, g 3202 ± 849 3240 ± 825 3172 ± 868 
Height-for-age Z-score3 -0.78 ± 0.98 -0.85 ± 0.91 -0.72 ± 1.02 
BMI-for-age Z-score3 0.10 ± 0.99 0.15 ± 1.06 0.05 ± 0.92 
C-reactive protein, mg/L 1.49 ± 3.25 1.22 ± 1.83 1.73 ± 4.08 
Plasma vitamin A, μmol/L 1.04 ± 0.33 1.04 ± 0.33 1.04 ± 0.33 
Maternal Education, y 8.7 ± 3.2 8.6 ± 3.2 8.7 ± 3.2 
Maternal Height, cm 157.8 ± 6.0 157.6 ± 5.9 158.1 ± 6.1 
Maternal BMI, kg/m2 24.2 ± 3.8 24.5 ± 3.9 24.0 ± 3.7 
Lowest Socioeconomic Status,4 % (N) 7.8 (43) 8.7 (22) 7.0 (21) 
1  Totals may be < 553 for all children, < 254 for boys, and < 299 for girls due to missing values. 
2  Values are Mean (SD) unless otherwise noted. 
  3  According to the World Health Organization 2007 growth reference for children 5-19 y. 











Table 3.2 Change in adiposity indicators in 254 school-age boys from Bogotá, Colombia, according to quartiles of LINE-1 DNA methylation 
 Quartiles of LINE-1 DNA methylation  
 
Q1                                                   
N = 64 
Q2                                      
N = 64 
Q3                                
N = 63 
Q4                                      
N = 63 P
1 
Median (Range) %5mC 79.05                         (76.26, 79.62) 
80.05                                               
(79.63, 80.59) 
80.90                    
(80.59, 81.40) 
82.20                                
(81.41, 85.24)  
BMI-for-age Z-score2 
     Baseline3 0.18 ± 1.09 0.20 ± 1.05 0.08 ± 0.99 0.14 ± 1.13 
 Change (/y)4 0.04 ± 0.02 -0.04 ± 0.03 0.00 ± 0.03 -0.02 ± 0.02 0.24 
Adjusted difference (95% CI)5 Reference -0.08 (-0.16, 0.00) -0.04 (-0.11, 0.03) -0.06 (-0.12, 0.01) 0.21 
      Waist Circumference Z-score6  
     Change (/y)4 0.05 ± 0.03 0.00 ± 0.03 0.00 ± 0.03 -0.03 ± 0.02 0.03 
Adjusted difference (95% CI)5 Reference -0.05 (-0.14, 0.04) -0.06 (-0.14, 0.02) -0.09 (-0.17, -0.02) 0.02 
      Skinfold Thickness Ratio Z-score6 
     Baseline3 -0.03 ± 0.91 0.13 ± 0.77 0.28 ± 0.84 0.03 ± 0.95 
 Change (/y)4 0.01 ± 0.03 -0.07 ± 0.03 -0.08 ± 0.03 -0.03 ± 0.02 0.32 
Adjusted difference (95% CI)5 Reference -0.08 (-0.16, 0.00) -0.09 (-0.17,-0.01) -0.04 (-0.12, 0.03) 0.28 
            
1 For a test of linear trend when a variable that represented the median value of each quartile was introduced into a linear regression model as a continuous 
predictor (Wald test). 
2  According to the World Health Organization growth reference for children 5-19 y (29). 
3 Values are means ± SD. 
4 Values are means ± SE. 
5 Adjusted for baseline age and socioeconomic status. 
6 Age-standardized using the LMS method (30) with data for boys 5-16 y of age in NHANES III. 
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Table 3.3 Change in adiposity indicators in 299 school-age girls from Bogotá, Colombia, according to quartiles of LINE-1 DNA methylation 
 Quartiles of LINE-1 DNA methylation  
 
Q1                                            
N = 75 
Q2                                      
N = 74 
Q3                                      
N = 75 
Q4                                       
N = 75 P
1 
Median (Range) %5mC 78.43                         (75.16, 79.23) 
79.65                                 
(79.23, 79.97) 
80.32                                    
(79.97, 80.89) 
81.52                                   
(80.91, 85.69)  
BMI-for-age Z-score2 
     Baseline3 0.09 ± 0.83 0.06 ± 0.95 -0.04 ± 0.91 0.09 ± 0.99 
 Change (/y)4 0.00 ± 0.02 0.05 ± 0.02 0.01 ± 0.02 0.00 ± 0.02 0.65 
Adjusted difference (95% CI)5 Reference 0.05 (-0.02, 0.11) 0.00 (-0.06, 0.07) -0.01 (-0.07, 0.06) 0.65 
      Waist Circumference Z-score6  
     Change (/y)4 0.00 ± 0.02 0.00 ± 0.03 0.03 ± 0.03 -0.01 ± 0.03 0.84 
Adjusted difference (95% CI)5 Reference 0.01 (-0.06, 0.08) 0.04 (-0.03, 0.11) -0.01 (-0.08, 0.06) 0.99 
      Skinfold Thickness Ratio Z-score6 
     Baseline3 0.03 ± 0.72 -0.01 ± 0.82 -0.09 ± 0.61 0.02 ± 0.57 
 Change (/y)4 0.00 ± 0.03 0.00 ± 0.03 0.01 ± 0.02 0.00 ± 0.03 0.87 
Adjusted difference (95% CI)5 Reference 0.00 (-0.08, 0.07) 0.01 (-0.05, 0.07) 0.00 (-0.07, 0.07) 0.85 
            
1 For a test of linear trend when a variable that represented the median value of each quartile was introduced into a linear regression model as a continuous 
predictor (Wald test). 
2  According to the World Health Organization growth reference for children 5-19 y (29). 
3 Values are means ± SD. 
4 Values are means ± SE. 
5 Adjusted for baseline age and socioeconomic status. 
6 Age-standardized using the LMS method (30) with data for girls 5-16 y of age in NHANES III. 
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Table 3.4 Change in height-for-age in 553 school-age children from Bogotá, Colombia, according to quartiles of LINE-1 DNA methylation1 
 Quartiles of LINE-1 DNA methylation  
 Q1                         Q2                          Q3                               Q4                           P
2
Boys 
     N 64 64 63 63 
 
Median (Range) %5mC 79.05                         (76.26, 79.62) 
80.05                                   
(79.63, 80.59) 
80.90                             
(80.59, 81.40) 
82.20                                
(81.41, 85.24)  
Baseline height-for-age Z-score3 -0.84 ± 1.01 -0.96 ± 0.96 -0.81 ± 0.90 -0.79 ± 0.78 
 Change (/y)4 0.04 ± 0.02 0.05 ± 0.02 0.04 ± 0.02 0.06 ± 0.02 0.48 
Adjusted difference (95% CI)5 Reference 0.01 (-0.05, 0.08) 0.00 (-0.06, 0.06) 0.02 (-0.03, 0.08) 0.55 
      Girls 
     N 75 74 75 75 
 
Median (Range) %5mC 78.43                         (75.16, 79.23) 
79.65                                 
(79.23, 79.97) 
80.32                                    
(79.97, 80.89) 
81.52                                   
(80.91, 85.69) 
 Baseline height-for-age Z-score3 -0.73 ± 0.90 -0.61 ± 1.19 -0.73 ± 0.88 -0.82 ± 1.11 
 Change (/y)4 0.06 ± 0.02 0.03 ± 0.02 0.03 ± 0.02 0.08 ± 0.02 0.54 
Adjusted difference (95% CI)5 Reference -0.02 (-0.08, 0.03) -0.03 (-0.08, 0.03) 0.02 (-0.04, 0.08) 0.54 
1 Height-for-age Z-scores were determined using the World Health Organization growth reference for children 5-19 y (29). 
 2 For a test of linear trend when a variable that represented quartiles was introduced into a linear regression model as a continuous predictor (Wald test). 
3 Values are mean ± SD. 
     4 Values are mean ± SE. 








Summary of Main Findings 
 This work extends current knowledge regarding nutritional and sociodemographic 
predictors of global DNA methylation, and contributes to the understanding of biological 
mechanisms that underlie early life obesity.  
In Chapter 2, we found that intake of methyl-donor and methylation cofactor 
micronutrients was not related to global DNA methylation in a large sample of healthy 
middle-aged adults.  However, we found a positive association between BMI and LINE-1 
methylation, which is corroborated by results from a study of Samoan adults (1).  Yet, 
other cross-sectional studies in adults have not found an association between DNA 
methylation and measures of adiposity (2-6), highlighting the need for longitudinal 
investigations to assess the causal relation of global DNA methylation with body size. 
We also found a positive correlation between height and Alu methylation, which is 
supported by preliminary findings from a U.S. birth cohort that higher cord blood global 
DNA methylation is related to greater height up to 7 y of age (7).  This association might 
reflect early life conditions, as height is a sensitive indicator of environmental influences 
that otherwise may not be quantifiable.  
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In Chapter 3, we found that higher plasma levels of plasma vitamin A and CRP, 
and low maternal BMI (< 18.5) were each associated with lower LINE-1 methylation, 
whereas higher household socioeconomic status was related to higher LINE-1 
methylation in healthy school-age children. The associations with vitamin A are in line 
with findings from studies of retinoic acid treatment in cancer cells, and could be related 
to diminished DNMT expression (8).  Plasma CRP concentration, an inflammation 
biomarker, was also inversely related to LINE-1 methylation.  Although the literature 
regarding inflammation and global DNA methylation in adults is inconsistent (9-11), this 
relation will be important to examine in other pediatric populations, as it sheds light on 
the pathogenesis atherosclerosis and other inflammation-mediated vascular disorders. 
The relations of maternal BMI and socioeconomic status with global DNA methylation 
could portray early life environmental influences on the epigenome. Assuming that 
maternal BMI is representative of the women’s pre-pregnancy weight status, the 
association between low maternal BMI and global DNA hypomethylation could reflect 
differences in the children’s early life nutrient environment. Studies from the Dutch 
Winter Famine cohort indicate that maternal undernourishment during the 
periconceptional period is associated with persistent changes in offspring DNA 
methylation profiles (12), and data from perinatal studies provide support for a positive 
correlation between pre-pregnancy BMI and cord blood DNA methylation (13, 14).  
Socioeconomic status also plays an important role in the early life environment. Lower 
socioeconomic status is associated with adverse prenatal exposures such as maternal 
cigarette smoking (15), and unhealthy lifestyle characteristics during childhood including 
poor diet and lack of exercise (16, 17) -  all of which are related to lower global DNA 
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methylation in adults (4, 5, 18).  Whether these associations represent epigenetic 
‘programming’ related to later-life health outcomes requires further investigation. As was 
consistent with findings from Chapter 2, there were no significant associations between 
methyl-donor (erythrocyte folate) or methylation cofactor micronutrients (plasma vitamin 
B12) and global DNA methylation.   
The null findings from Chapters 2 and 3 surrounding the methyl-donor and 
methylation cofactor micronutrients could be related to the nutritional status of the study 
populations.  Considering the folic acid fortification of the U.S. food supply, and the low 
prevalence of folate deficiency in the Bogotá  school children (19), it is likely that few 
participants in either study were folate-deficient.  A positive association of folate intake 
or status with DNA methylation might be detectable in populations with a higher 
prevalence of methyl-donor micronutrient deficiencies.  Additionally, we only examined 
specific micronutrients, which does not account for the combinations of foods and 
nutrients in the human diet that may interact to promote DNA methylation (5).  Finally, it 
is important to acknowledge that we were not able to examine associations with choline, 
which also plays an important role in the metabolic cycling of homocysteine. Because the 
folate- and choline-mediated methylation pathways may be interrelated (20, 21), future 
studies should examine associations of both micronutrients with global DNA 
methylation. 
 In Chapter 4, we shifted focus to the relation of global DNA methylation with 
child growth.  Among boys, we found inverse, non-linear relations of LINE-1 
methylation with change in BMI-for-age Z-score and skinfold thickness ratio-for-age Z-
score.  Boys in the lowest quartile of LINE-1 methylation experienced greater annual 
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gains in BMI and the skinfold thickness ratio than those in the upper three quartiles 
during follow-up.  In addition, lower LINE-1 methylation was related to greater gains in 
waist circumference-for-age in a linear fashion.  These results indicate that lower global 
DNA methylation is related to development of adiposity school-age boys.  On the other 
hand, there were no significant associations between global DNA methylation and any of 
the adiposity indicators among girls, and LINE-1 methylation was not related to linear 
growth in either sex.   
This dissertation has several strengths.  Many epigenetic studies had small sample 
sizes and were underpowered to detect small differences in global DNA methylation.  We 
were able to examine global DNA methylation in a large sample of healthy, ethnically 
diverse middle-age adults, as well as in a large and representative sample of school-age 
children from a setting where child overweight is becoming a serious public health 
concern.  The prospective design and use of repeated anthropometric measures in Chapter 
4 enhanced our ability to assess the temporal relation between LINE-1 methylation and 
changes in body composition.  Global DNA methylation was quantified using a highly-
reproducible pyrosequencing-based technology.  We also used DNA from peripheral 
leukocytes, which are of high intrinsic value in epidemiologic studies as it is easily 
obtained and reflects systemic interindividual variation in germ-layer cells (22).  This 
work also has some limitations.  We did not account for the proportion of white blood 
cell subtypes in the analyses.  There is some evidence that global DNA methylation is 
negatively related to the percentage of lymphocytes (2); whether differential leukocyte 
counts are associated with development of adiposity is a possibility that warrants further 
investigation.  Additionally, comparability of findings regarding global DNA methylation 
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is limited due to inconsistencies in laboratory techniques and assays used to quantify 
genomic methylation content in the literature.  Finally, because global DNA methylation 
may serve only as a biomarker of concomitant molecular mechanisms, these findings 
provide a basis for further investigation of mechanistic pathways, such as gene-specific 
DNA methylation, involved in the etiology of excess weight gain.  Future studies could 
examine methylation of genes implicated in adipogenesis, such as the retinoid X receptor 
alpha (RXRA) (23) and the peroxisome proliferator-activated receptors (PPARs) (24), in 




Public Health Implications 
While we did not find significant associations between methyl donor/methylation 
cofactor micronutrients and global DNA methylation in adults or children, we identified 
important sociodemographic and nutritional correlates of global DNA methylation.  The 
positive association between height and Alu methylation in the MESA population is 
noteworthy, since short adult stature is associated with risk of some chronic diseases, 
such as cardiovascular disease (25, 26).  Elucidating the role of DNA methylation in 
linear growth would improve understanding of regulatory mechanisms involved in human 
development, and may also provide insight on disease etiology.  In the BSCC children, 
vitamin A status, plasma CRP, maternal BMI, and socioeconomic status were each 
associated with LINE-1 methylation.  Although the health consequences of altered LINE-
1 methylation in children require additional research, and longitudinal investigations are 
necessary to determine whether modification of these exposures during the school-age 
years leads to changes in DNA methylation, linking modifiable characteristics, such as 
maternal weight status and child nutritional status, to a reversible epigenetic mechanism 
can unveil viable avenues for intervention opportunities.   
Perhaps the most salient finding of this dissertation is the inverse relation between 
global DNA methylation and development of adiposity in boys.  The fact that change in 
waist circumference was strongly associated with LINE-1 methylation is especially 
important because abdominal adiposity has disproportionate consequences for metabolic 
physiology.  Central fat mass is related to increased cardiovascular morbidity (27) and 
mortality (28) in adults.  Furthermore, recent findings indicate that accrual of abdominal 
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fat during childhood is a strong independent predictor of poor cardiometabolic health in 
later life (29).   
In light of evidence that aberrations in DNA methylation are reversible via dietary 
changes (30), our findings point toward opportunities for public health intervention.  For 
example, changes in child nutritional status could feasibly be accomplished through 
school meal programs.  Additionally, the fact that children of underweight mothers 
exhibited lower global DNA methylation than their counterparts suggests that the 
documented relation between gestational nutrient restriction and risk of adult chronic 
disease (31) may be mediated by epigenetic mechanisms.  Primary healthcare settings are 
a practical venue to target underweight reproductive-aged women for nutrition education.  
Such interventions aimed at modifiable epigenetic mechanisms are relatively 
inexpensive, readily available, and could become a public health priority.  
As epigenetic research continues to evolve and progress, we anticipate that studies 
evaluating the influence of dietary interventions on DNA methylation profiles and 
subsequent changes in body composition will improve knowledge of biological pathways 
that underlie excess weight gain.  Findings will have important implications for the 
development of effective intervention programs, as well as clinical recommendations 
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